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Summary statement 28 
The cortical collapse factor Efa6 limits axon growth and branching and maintains axonal 29 
microtubule bundle integrity by inhibiting microtubule polymerisation at the cell cortex. 30 
 31 
Abstract  32 
Cortical collapse factors affect microtubule (MT) dynamics at the plasma membrane. They 33 
play important roles in neurons, as suggested by inhibition of axon growth and regeneration 34 
through the Arf activator Efa6 in C. elegans, and by neurodevelopmental disorders linked to 35 
the mammalian kinesin Kif21A. How cortical collapse factors influence axon growth is little 36 
understood. Here we studied them, focussing on the function of Drosophila Efa6 in 37 
experimentally and genetically amenable fly neurons. First, we show that Drosophila Efa6 can 38 
inhibit MTs directly without interacting molecules via an N-terminal 18 amino acid motif (MT 39 
elimination domain/MTED) that binds tubulin and inhibits microtubule growth in vitro and cells. 40 
If N-terminal MTED-containing fragments are in the cytoplasm they abolish entire microtubule 41 
networks of mouse fibroblasts and whole axons of fly neurons. Full-length Efa6 is membrane-42 
attached, hence primarily blocks MTs in the periphery of fibroblasts, and explorative MTs that 43 
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have left axonal bundles in neurons. Accordingly, loss of Efa6 causes an increase of 44 
explorative MTs: in growth cones they enhance axon growth, in axon shafts they cause 45 
excessive branching, as well as atrophy through perturbations of MT bundles. Efa6 over-46 
expression causes the opposite phenotypes. Taken together, our work conceptually links 47 
molecular and sub-cellular functions of cortical collapse factors to axon growth regulation and 48 
reveals new roles in axon branching and in the prevention of axonal atrophy. Furthermore, the 49 
MTED delivers a promising tool that can be used to inhibit MTs in a compartmentalised 50 
fashion when fusing it to specifically localising protein domains.  51 
 52 
Introduction 53 
Axons are the cable-like neuronal extensions that wire the nervous system. They are only 0.1-54 
15µm in diameter (Hoffman, 1995), but can be up to a meter long in humans (Debanne et al., 55 
2011; Prokop, 2013a). It is a fascinating challenge to understand how axons can extend over 56 
these enormous distances and branch in orderly manners, but also how these delicate 57 
structures can be maintained for a lifetime, i.e. many decades in humans. It is not surprising 58 
that we gradually lose about 40% of our axons towards old age (Calkins, 2013; Marner et al., 59 
2003), and that axon decay is a prominent neurodegenerative phenomenon (Adalbert and 60 
Coleman, 2012; Fang and Bonini, 2012; Medana and Esiri, 2003; Wang et al., 2012).  61 
Essential for axon biology are the parallel bundles of microtubules (MTs) running all 62 
along the axon shaft; these bundles provide (1) structural support, (2) highways for life-63 
sustaining cargo transport, and (3) a source of MTs that can leave these bundles to drive 64 
morphogenetic changes. Through being organised in this way, MTs essentially drive 65 
processes of axon growth, branching and maintenance (Conde and Caceres, 2009; Dent et al., 66 
2011; Prokop, 2013a; Voelzmann et al., 2016a). The dynamics of MTs are orchestrated 67 
through MT-binding and -regulating proteins, for most of which we know the molecular 68 
mechanisms of function. However, such knowledge alone is usually not sufficient to explain 69 
their cellular roles.    70 
For example, cortical collapse factors are cell surface-associated proteins which 71 
specifically inhibit MTs that approach the cell periphery. Previous reports suggested important 72 
roles for cortical collapse factors in regulating axon growth: the ARF activator Efa6 (exchange 73 
factor for ARF6) in C. elegans negatively impacts on developmental and regenerative axon 74 
growth (Chen et al., 2015; Chen et al., 2011; O'Rourke et al., 2010); the mammalian type 4 75 
kinesin KIF21A also affects axon growth and links to the neurodevelopmental eye movement 76 
disorder "congenital fibrosis of extraocular muscles" (OMIM reference #135700; Heidary et al., 77 
2008; Tiab et al., 2004; van der Vaart et al., 2013). However, we can currently only 78 
hypothesise how the molecular functions of these two collapse factors link to axon growth, 79 
most likely by acting in growth cones (GCs).  80 
GCs are the amoeboid tip structures through which axons extend to wire the nervous 81 
system during development or regeneration. The axonal MT bundles terminate in the centre of 82 
GCs; from here, single MTs splay into the actin-rich periphery of GCs. These explorative MTs 83 
can trigger extension of the entire MT bundle into their direction, thus elongating the axon 84 
(Dent et al., 2011; Lowery and van Vactor, 2009; Prokop et al., 2013); by inhibiting such 85 
explorative MTs, cortical collapse factors could negatively impact on axon growth.  86 
In line with this argumentation, and depending on where cortical collapse factors are 87 
present and functionally active, further functional predictions could be made: for example, 88 
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collateral branching of axons along their shafts has been described to depend on explorative 89 
MTs that leave the parallel axonal bundles and polymerise towards the periphery (Kalil and 90 
Dent, 2014; Lewis et al., 2013; Tymanskyj et al., 2017; Yu et al., 2008). Cortical collapse 91 
factors might therefore be negative regulators of axon branching.  92 
Other roles might concern axon maintenance: the model of 'local axon homeostasis' 93 
states that the force-enriched environment in axons biases MTs to buckle or project out of the 94 
bundle to seed pathological areas of MT disorganisation (Hahn et al., 2019; Prokop, 2016). By 95 
inhibiting off-track MTs in the axon shaft, cortical collapse factors might prevent such 96 
processes, acting in parallel to other bundle-maintaining factors. For example, spectraplakins 97 
serve as spacers that keep polymerising MTs away from the cortex by linking the tips of 98 
extending MTs to the axonal surface and guiding them into parallel bundles (Alves-Silva et al., 99 
2012). Their deficiency in any organism causes severe MT disorganisation, potentially 100 
explaining human dystonin-linked HSAN6 ('type 6 hereditary sensory and autonomic 101 
neuropathy''; #614653; Voelzmann et al., 2017). If our hypothesis is correct, loss of cortical 102 
collapse factors in axon shafts would also cause MT disorganisation, but through a very 103 
different mechanistic route.    104 
 Here we make use of Drosophila neurons as a well-established, powerful model for 105 
studying roles of MT regulators (He and Roblodowski, 2016; Nye et al., 2014; Prokop et al., 106 
2013; Sánchez-Soriano et al., 2007). Using in vitro and cellular assays, we show that 107 
Drosophila Efa6 is a cortical collapse factor acting through its N-terminal MT-eliminating 108 
domain (MTED). We find that the MTED binds tubulin and blocks MT polymerisation in vitro 109 
which indicates that the effect of the peptide is due to a direct interaction between the peptide 110 
and tubulin. By localising to neuronal membranes, it only abolishes explorative MTs. This 111 
subcellular role translates into negative regulation of axon growth and branching and the 112 
prevention of pathological MT disorganisation, both in cultured neurons and in vivo. We 113 
propose Efa6 to function as a quality control or axonal maintenance factor that keeps 114 
explorative MTs in check, thus playing a complementary role to spectraplakins that prevent 115 
MTs from leaving axonal bundles.             116 
 117 
Results 118 
Efa6 is widely expressed in Drosophila neurons and restricts axonal growth  119 
To evaluate the function of Efa6 in neurons, we first determined its expression in the nervous 120 
system. We used a genomically engineered fly line in which the endogenous Efa6 gene was 121 
GFP-tagged (Efa6-GFP; Huang et al., 2009). These animals widely express Efa6::GFP 122 
throughout the CNS at larval and adult stages (Figure 1A-D). We cultured primary neurons 123 
from this fly line to analyse the subcellular distribution of Efa6. In young neurons at 6 hrs in 124 
vitro (6HIV) and in mature neurons at 5 days in vitro (5DIV), Efa6 was localised throughout 125 
cell bodies and axons (Figure 1E,F,H,I).  126 
We next determined whether Drosophila Efa6 has an impact on axon growth, using a range of 127 
loss-of-function conditions: Efa6 knock-down (Efa6-RNAi), two overlapping deficiencies 128 
uncovering the entire Efa6 gene locus (Efa6Def), and three precise gene deletions including 129 
Efa6GX6[w+], Efa6GX6[w-] and Efa6KO#1 (see methods for details; Huang et al., 2009). In all these 130 
conditions, axon length at 6 HIV was increased compared to wild-type by at least 20% (Figure 131 
2A,B,D). Since there were no obvious differences between the precise deletion lines, these 132 
alleles were used interchangeably for further experiments. 133 
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We then tested whether over-expression of Efa6 would cause the opposite effect, i.e. axon 134 
shortening or even loss. For this, we generated a transgenic UAS-Efa6-FL-GFP line and, in 135 
addition, developed methods to transfect UAS-constructs into Drosophila primary neurons 136 
(see Methods). As similarly observed with the endogenous protein, full-length Efa6-FL::GFP 137 
localised to cell bodies, axons and growth cones of primary neurons also when expressed 138 
pan-neuronally using either the transgenic line (Figure 1G) or cell transfection (Figure 3-figure 139 
supplement 1B). The transgenic expression caused a ~20% reduction in axon length, which 140 
was increased to ~50% upon transfection (likely due to higher copy numbers of the expression 141 
construct; Figure 2C,D). Furthermore, we observed an increase in the number of neurons 142 
without axons from ~26% in UAS-GFP-transfected controls to ~43% in Efa6-FL::GFP-positive 143 
neurons (Figure 3B,F',F'').  144 
Together, these results suggest that Efa6 restricts axonal growth, comparable to reports for C. 145 
elegans Efa6 (CeEfa6; Chen et al., 2015; Chen et al., 2011). The loss of whole axons upon 146 
Efa6-FL::GFP over-expression might suggest that Efa6 performs its morphogenetic roles by 147 
inhibiting MT networks.  148 
 149 
Efa6 eliminates peripheral or even entire MT networks in mouse fibroblasts 150 
To assess whether the negative impact of Efa6 on axon outgrowth might be through inhibiting 151 
MTs, we used NIH3T3 mouse fibroblasts as a heterologous cell system known to provide 152 
meaningful readouts for functional studies of Drosophila MT regulators (Alves-Silva et al., 153 
2012; Beaven et al., 2015). When fibroblasts were analysed 24 hrs after transfection with 154 
Efa6-FL-GFP, we found a graded depletion of MT networks depending on Efa6-FL::GFP 155 
protein levels (shown and quantified in Figure 3-figure supplement 2). At low or moderate 156 
expression levels, Efa6-FL::GFP localised along the circumference and in areas of membrane 157 
folds (open arrow heads in Figure 3-figure supplement 2A,B), and MTs tended to be lost 158 
predominantly from the cell fringes (curved arrows in Figure 3-figure supplements. 2B and 159 
3B). At high expression levels, Efa6-FL::GFP became detectable in the cytoplasm and even 160 
nucleus (double-chevrons in  Figure 3-figure supplement 2C), suggesting that membrane-161 
association might become saturated. In these cases, prominent MT networks were gone 162 
(Figure 3-figure supplement 2C). When quantifying these MT phenotypes across all 163 
transfected fibroblasts, there was a strong increase in MT network defects and depletion upon 164 
Efa6-FL::GFP expression, but not in GFP controls (Figure 3B). 165 
When performing live analyses, we consistently observed that growing MTs labelled with 166 
EB3::mCherry extended to the very cell fringes of control fibroblasts (Figure 4A; Video 1), 167 
whereas MTs in fibroblasts transfected with Efa6-FL::GFP showed a very different behaviour: 168 
hardly any MTs polymerised into areas along the rim where Efa6 was enriched but stopped at 169 
the border of the expression zone, often accompanied by Efa6-FL::GFP accumulation at MT 170 
plus ends at the invasion site (Figure 4B,D,E; Video 2). 171 
Taken together, these fibroblast experiments confirm MT-inhibiting functions of Efa6. They 172 
suggest that Efa6 is membrane-associated and excludes MTs from this position, which may 173 
similarly apply also to roles of Efa6 in neuronal morphogenesis. We concluded that the 174 
complementary use of mouse fibroblasts and Drosophila primary neurons provides an 175 
informative combination of readouts for MT loss and axon morphology - ideal to carry out a 176 
systematic structure-function analysis of Efa6. 177 
 178 
The N-terminal 18aa motif of Efa6 is essential for microtubule-inhibiting activity of Efa6   179 
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A detailed analysis of the domain structures of Efa6 proteins from 30 species revealed that C-180 
termini of almost all species contain a putative pleckstrin homology domain (PH; potentially 181 
membrane-associating; Macia et al., 2008), a Sec7 domain (potentially activating Arf 182 
GTPases; D'Souza-Schorey and Chavrier, 2006; Huang et al., 2009) and a coiled-coil (CC) 183 
domain (Franco et al., 1999; Figure 3A, Figure 3-figure supplement 4A). In contrast, the N-184 
termini are mainly unstructured and reveal enormous length differences among species. 185 
Accordingly, phylogenetic relationship analyses comparing either full-length or N-terminal 186 
Efa6, show that chordate proteins are rather distant from invertebrates, and that arthropods 187 
form a clear subgroup within the invertebrates (Figure 3-figure supplement 5A,B). None of the 188 
identifiable N-terminal domains/motifs is particularly well conserved (details in Figure 3A, 189 
Figure 3-figure supplement 4A). For example, the Drosophila N-terminus contains (1) a 190 
putative PDZ domain (aa16-88; mainly found in insect versions of Efa6), (2) two SxIP motifs 191 
(aa 233-6 and 262-5; found primarily in Efa6 of flies, some other insects and molluscs; some 192 
vertebrate/mammalian species display derived SxLP motifs), and (3) a motif of 18aa (from 193 
now on referred to as MT elimination domain, MTED) displaying 89% similarity with a motif in 194 
the N-terminus of CeEfa6 suggested to be involved in MT inhibition (O'Rourke et al., 2010; 195 
conserved in nematodes, arthropods and molluscs).  196 
To assess potential roles of the 18aa long Drosophila MTED, we generated a series of GFP-197 
tagged N-terminal constructs (Figure 3B): Efa6-Cterm-GFP (encoding the entire N-terminal 198 
half upstream of the Sec7 domain), Efa6-Nterm-GFP (restricting to the N-terminal part 199 
containing all the identified functional domains), Efa6-NtermMTED-GFP (lacking the MTED) 200 
and Efa6-MTED-GFP (encoding only the MTED). All these N-terminal Efa6 variants showed 201 
localisation throughout neurons (Figure 3-figure supplement 1C,D,F,G), and in the cytoplasm 202 
and nucleus of fibroblasts (Figure 3-figure supplement 6C,D,F,G). Cytoplasmic and nuclear 203 
localisations occurred even at low expression levels, indicating that the absent C-terminus 204 
(and likely PH domain within) usually mediates membrane association. This nuclear 205 
localisation occurs in the absence of any predicted N-terminal nuclear localisation sequences 206 
(Figure 3A, Figure 3-figure supplement 4A), likely reflecting a known artefact of GFP-tagged 207 
proteins (Alves-Silva et al., 2012; Seibel et al., 2007). 208 
In spite of their very similar localisation patterns, the functional impact of these constructs was 209 
clearly MTED-dependent: only constructs containing the MTED (Efa6-Cterm::GFP, Efa6-210 
Nterm::GFP and Efa6-MTED::GFP) caused strong axon loss in neurons and MT network 211 
depletion in fibroblasts, whereas Efa6-NtermMTED::GFP caused no phenotypes in fibroblasts 212 
and very mild axon loss in neurons (Figure 3B; Figure 3-figure supplement 1C,D,F,G; Figure 213 
3-figure supplement 3C,D,G,H). Potential tendencies of Efa6-NtermMTED::GFP to cause some 214 
aberration, were complemented by findings that MTED::GFP-induced effects were less strong 215 
than those by two longer N-terminal constructs (Figure 3B). This might suggest that there are 216 
some relevant N-terminal motifs or regions outside the MTED.  217 
Likely candidates are the two SxIP motifs predicted to bind EB proteins (Honnappa et al., 218 
2009; Figure 3A). Accordingly, we found that Efa6-Nterm::GFP tip-tracks, and that Efa6-219 
FL::GFP and EB3::RFP co-localise at points where MTs enter Efa6-FL::GFP-rich areas in 220 
fibroblast (Videos 2 and 3). Such binding to EBs at MT plus ends, might enhance Efa6's ability 221 
to capture MTs for inhibition. However, when replacing each of the two SxIP motifs by four 222 
alanines, we found that the resulting Efa6-Nterm∆SxIP::GFP construct induced similarly strong 223 
axon loss in neurons and MT network depletion in fibroblasts as observed with Efa6-224 
Nterm::GFP (Figure 3B, Figure 3-figure supplement 1D,E, Figure 3-figure supplement 3D,F, 225 
Figure 3-figure supplement 6D,E). Similar observations were reported for Kif2C which clearly 226 
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tip-tracks MTs in an EB1-dependent manner but does not require this property for its MT-227 
depolymerising activity (Moore et al., 2005).  228 
In conclusion, there might be some unidentified support sequences in the N-terminus, but our 229 
results clearly pinpoint the MTED as the key mediator of Drosophila Efa6's MT-depleting 230 
functions, suggesting this function to be conserved between flies and C. elegans.  231 
 232 
The MTED is a good predictor of MT-inhibiting function directly affecting MT polymerisation 233 
To assess whether the MTED motif is a good predictor for MT-inhibiting capabilities of Efa6 234 
family members, we used 12 different constructs: full length versions of (1) CeEfa6, (2) 235 
Drosophila Efa6 and (3-6) all four human PSDs (Figure 3C), as well as N-terminal versions of 236 
(7) CeEfa6, (8) fly Efa6 and (9) human PSD1 (Figure 3D). Furthermore, we deduced a MTED 237 
consensus sequence from 39 Efa6 genes (details in  Figure 3-figure supplement 4C), 238 
identified the most likely human MTED-like sequence (position 31-49aa of PSD1; MTED-core 239 
in Figure 3A) and synthesised codon-optimised versions of (10) this human as well as the (11) 240 
fly and (12) worm MTEDs (Figure 3-figure supplement 4B,C). When transfected into 241 
fibroblasts, we found that all 6 fly/worm constructs had strong MT-inhibiting properties, 242 
whereas the 6 human constructs (PSD1-4 full length, PSD1-Nterm, PSD1-MTED-like) showed 243 
only a slight increase in MT network defects that were far from the strong MT depletion 244 
observed with the fly/worm constructs; complete depletion of MT networks was never 245 
observed with the human constructs (Figure 3C-E). Therefore, the presence of a well 246 
conserved canonical MTED seems to be a good predictor for MT-inhibiting capabilities of Efa6 247 
proteins. 248 
To gain insights into the mechanisms through which MTEDs might act, we carried out a series 249 
of in vitro experiments. Purified Efa6-Nterm::GFP clearly associated with MTs in vitro (Figure 250 
4-figure supplement1A), but failed to depolymerise MTs (Figure 4-figure supplement 1B). We 251 
therefore tested the same protein in Xenopus oocyte extract to assess potential co-factor 252 
requirements, but saw again no activity (Figure 4-figure supplement 1C) - in spite of the fact 253 
that injection of a corresponding mRNA into Xenopus oocytes caused strong cell division 254 
phenotypes (Figure 4-figure supplement 1D,E).  255 
We suspected problems with recombinant expression of Efa6-Nterm::GFP which is predicted 256 
to have large disordered regions. We used therefore synthetic MTED peptide as an alternative 257 
approach and tested it in MT growth assays (Figure 4G,H). We found that the amount of MT 258 
polymer produced in control MT growth assay conditions without peptide, was approximately 259 
10-fold reduced when synthetic MTED peptide was added, whereas a scrambled version of 260 
the peptide failed to show this effect (Figure 4G,H). The effect of the MTED peptide is not as 261 
potent as that of the well characterised MT depolymerising kinesin, KIF2C/MCAK (mitotic 262 
centromere-associated kinesin), which can completely inhibit MT growth at lower 263 
concentrations but requires ATP to this end (Figure 4G,H). 264 
The MT growth assay suggested that MTED can directly interfere with MT polymerisation in 265 
the absence of any auxiliary factors, and the decoration of MTs with Efa6-Nterm::GFP in our 266 
in vitro binding assays ( Figure 4-figure supplement 1A) is in agreement with this notion. To 267 
confirm direct interaction with tubulin, we coated sepharose beads with MTED and pulled 268 
down un-polymerised GDP-tubulin. We found that the MTED-coated beads pulled down 3 269 
times more tubulin than the same beads uncoated, and 5 times more tubulin than beads 270 
coated with a scrambled version of the peptide (Figure 4F, top). These data indicate a direct 271 
interaction of the MTED peptide with tubulin and suggest that a scrambled version of this 272 
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peptide appears to passivate the bead surface reducing non-specific interaction of tubulin. 273 
When using the same set-up for MCAK and comparing it to uncoated beads, approximately 274 
1.5 times more tubulin is pulled down by beads coated with MCAK in the presence of either 275 
AMPPNP or ADP (Figure 4F bottom; MCAK is known to strongly bind tubulin in the AMPPNP 276 
state and weakly bind tubulin in the ADP state; Wagenbach et al., 2008). In these 277 
experiments, the overall amount of tubulin pulled down with MCAK was considerably lower 278 
than with MTED; this is not surprising when considering (1) that far fewer of the large MCAK 279 
molecules can be accommodated on the beads, (2) that the tubulin-binding domain via its four 280 
lysines could be a frequent site of bead attachment, thus blocking access for tubulin, and (3) 281 
that the conditions required for this method of bead attachment  were less favourable for 282 
retention of activity than in previous binding assays (Wagenbach et al., 2008) 283 
Taken together, the MTED exists primarily in Efa6 homologues of invertebrate species and its 284 
presence correlates with MT-inhibiting properties of these proteins. This conclusion is strongly 285 
supported by our finding that Drosophila MTED directly interferes with MT polymerisation. This 286 
can explain why MTs fail to enter Efa6-enriched areas in fibroblasts (Figure 4B; Video 2).  287 
 288 
The C-terminal domain restricts the microtubule-inhibiting activity of Efa6 to the cortex   289 
Our structure-function analyses strongly suggested that Efa6 is membrane-associated. This is 290 
further supported by the observation that fibroblasts expressing Efa6-FL::GFP or the C-291 
terminal derivative Efa6-∆Nterm::GFP (Figure 3B), display a membrane ruffle phenotype 292 
(curved open arrows in Figure 3-figure supplements 6B,H and 7B,D). Efa6-∆Nterm::GFP had 293 
no obvious effects on MT networks (Figure 3-figure supplement 3I), and its membrane ruffling 294 
phenotype likely reflects an evolutionarily conserved function of the Efa6 C-terminus through 295 
its Sec7, PH and/or CC domains (Derrien et al., 2002; Franco et al., 1999; Macia et al., 2008). 296 
Accordingly, we find the same membrane ruffling when expressing PSD1-FL::GFP (curved 297 
open arrows in Figure 3-figure supplement 7E).  298 
However, even if the C-terminus plays no active role in the MT inhibition process, it still 299 
regulates this function: the Efa6-Cterm::GFP and Efa6-Nterm::GFP variants which lack the 300 
C-terminus (Figure 3B), fail to associate with the cortex (Figure 3-figure supplement 6C,D), do 301 
not cause ruffling (Figure 3-figure supplement 7C), but induce MT phenotypes far stronger 302 
than Efa6-FL::GFP does (Figure 3B and Figure 3-figure supplement 3C,D,H vs B). To assess 303 
whether lack of membrane tethering could explain this phenotypic difference, we generated 304 
the Efa6-Nterm::GFP::CAAX variant (Figure 3B) where Efa6-Nterm::GFP is fused to the 305 
membrane-associating CAAX domain (Hancock et al., 1991); this addition of CAAX changed 306 
the properties of Efa6-Nterm::GFP back to Efa6-FL::GFP-like behaviours in that the hybrid 307 
protein localised to the cortex and caused only a moderate MT phenotype in fibroblasts, and 308 
also the axon loss phenotype was mild (Figure 3B; Figure 3-figure supplements 6B,I; 3B,E). 309 
Also in live analyses, the CAAX construct reproduced the effect of excluding MTs from Efa6-310 
N-term::GFP::CAAX-enriched areas, confirming that this inhibition is mediated by the N-311 
terminus (Figure 4C-E; Video 4). These findings confirm membrane tethering as an important 312 
regulatory feature restricting Efa6 function.  313 
Taken together, our structure-function data clearly establish Drosophila Efa6 as a cortical 314 
collapse factor: its N-terminal MTED blocks MT polymerisation, and this function is restricted 315 
to the cortex through the Efa6 C-terminus which associates with the cell membrane. 316 
 317 
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Efa6 negatively regulates MT polymerisation at the growth cone membrane and in filopodia  318 
We next asked how Efa6's cortical collapse function relates to the observed axon growth 319 
phenotypes. For this, we focussed on growth cones (GCs) as the sites where axons extend; 320 
this extension requires the splaying of MTs from the axonal bundle tip at the base of GCs to 321 
explore the actin-rich periphery (Dent et al., 2011; Lowery and van Vactor, 2009; Prokop et al., 322 
2013). 323 
In GCs of primary neurons at 6 HIV, loss of Efa6 caused an increase in MT polymerisation 324 
events: the total number of Eb1 comets was increased as compared to wild-type controls 325 
(Figure 5I). Eb1::GFP comets in wild-type neurons tended to die down upon hitting the plasma 326 
membrane within GCs or at the tip of their filopodia, whereas they frequently persisted in Efa6 327 
mutant neurons, where they could occasionally even be observed to undergo curved 328 
extensions along the periphery (Videos 5-8). Comet velocity was unaffected (~0.14 μm/s), but 329 
the lifetime of Eb1::GFP comets (5.04 s ± 0.60 SEM in wild-type) was ~1.4 times longer in 330 
mutant GCs, with the dwell time of Eb1 comets at the tip of filopodia being ~3-fold increased 331 
(from 2.10 ± 0.24 s in wild-type to 6.26 ± 0.40 s in Efa6 mutant neurons; Figure 5M); we even 332 
observed cases where comets at the tips of filopodia were moving backwards, seemingly 333 
pushed back by the retracting filopodial tips (Videos 7, 8). In agreement with the increased 334 
lifetime, more MTs invaded growth cone filopodia in Efa6 mutant neurons, as quantified by 335 
counting filopodia that contained EB1comets or MTs (Figure 5J,K and arrow heads in D,E,; 336 
note that the total number of filopodia per GC was in the range of 10-11 for both wild-type and 337 
Efa6; not shown). Transgenically expressed Efa6-FL::GFP caused the opposite effect, i.e. a 338 
reduction in the number of GC filopodia containing Eb1 comets or MTs (Figure 5G-L; green 339 
columns). 340 
Next, we investigated MT dynamics in axon shafts. In contrast to GCs, MTs in the axon shaft 341 
are organised into bundles, hence kept away from the membrane. Accordingly, neither loss- 342 
nor gain-of-function had an obvious effect on Eb1 comet numbers, lifetimes, velocities and 343 
directionalities (Figure 6A-D). However, like in GCs, there was a strong increase in filopodia 344 
along the shaft that contained MTs when Efa6 was absent, and a strong decrease when over-345 
expressing Efa6-FL::GFP (Figure 6E-G).  346 
Taken together, our data are consistent with a model in which Efa6 primarily inhibits 347 
explorative MTs that leave the axon bundle in either GCs or axon shafts and polymerise 348 
towards the cell membrane or into filopodia. Surplus MTs in the periphery of GCs can explain 349 
the extra axonal growth we observed (Figure 2).   350 
 351 
Efa6 negatively influences axon branching 352 
We hypothesised that an increase in explorative MTs could also cause a rise in axon 353 
branching (see Introduction), either by inducing GC splitting through parallel growth events in 354 
the same GC (Acebes and Ferrus, 2000), or by seeding new collateral branches along the 355 
axon shaft (Kalil and Dent, 2014; Lewis et al., 2013). To test this possibility, we studied mature 356 
primary neurons at 5 days in vitro (DIV). We found that Efa6KO#1 homozygous mutant neurons 357 
showed almost double the number of collateral branches as observed in wild-type neurons, 358 
whereas expression of Efa6-FL::GFP reduced branching by 21% (Figure 7A-C,E). This 359 
reduction is mediated by the Efa6 N-terminus, since expression of Efa6-Nterm::GFP::CAAX 360 
caused a similar degree in branch reduction (Figure 7D,E). 361 
To extend these studies to neurons in vivo, we studied dorsal cluster neurons, a subset of 362 
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neurons with stereotypic axonal projections in the optic lobe of adult brains (Hassan et al., 363 
2000; Voelzmann et al., 2016b). To manipulate Efa6 levels in these neurons, either Efa6-RNAi 364 
or Efa6-FL-GFP was co-expressed with the membrane marker myr-tdTomato. Brains of young 365 
and old flies (2-5 d and 15-18 d after eclosure from the pupal case, respectively) were 366 
assessed with anti-GFP for specific Efa6-FL::GFP expression (Figure 7-figure supplement 1), 367 
and tdTomato was used to visualise axonal morphology (Figure 7F-K). We found that Efa6 368 
knock-down in dorsal cluster neurons caused a significant increase in branch numbers by 29% 369 
in young and by 38% in old brains, whereas over-expression of Efa6::GFP strongly decreased 370 
branch numbers by 33% in young and 28% in old brains, respectively (Figure 7L).  371 
In these experiments, Efa6-FL::GFP expression had an intriguing further effect: Only 57% of 372 
young brains had any axons in the medulla region, compared to 88% in controls, whereas the 373 
axons were eventually present in the older Efa6-FL::GFP expressing fly brains (Figure 7H,K,M, 374 
Figure 7-figure supplement 1B,D). This suggests a delayed outgrowth phenotype, as would be 375 
consistent with decreased axon growth observed upon Efa6 over-expression in primary 376 
neurons (green bars in Figure 2D). 377 
Taken together, our data indicate a physiologically relevant role of Efa6 as negative regulator 378 
of axonal branching, mediated through its N-terminus, most likely via its function as cortical 379 
collapse factor.  380 
 381 
Efa6 maintains axonal MT bundle integrity in cultured neurons 382 
Apart from changes in growth and branching, we noticed that a significant amount of Efa6-383 
depleted neurons displayed axons with swellings where MTs lost their bundled conformation 384 
and were arranged into intertwined, criss-crossing curls instead (arrowheads in Figure 8D-F). 385 
To quantify the strength of this phenotype, we measured the area of MT disorganisation 386 
relative to axon length (referred to as ’MT disorganisation index’, MDI; Qu et al., 2017). MDI 387 
measurements in Efa6 mutant neurons revealed a mild 1.3 fold increase in MT disorganisation 388 
in young neurons which gradually worsened to 2.3 fold at 5 DIV and ~4 fold at 10 DIV (Figure 389 
8A-F,I; all normalised to controls).  390 
The observed gradual increase in phenotype could be the result of a genuine function of Efa6 391 
not only during axon growth but also their subsequent maintenance. Alternatively, it could be 392 
caused by maternal gene product deposited in the mutant embryos by their heterozygous 393 
mothers (Prokop, 2013b); such maternal Efa6 could mask mutant phenotypes at early stages 394 
so that they become apparent only after most Efa6 has degraded. To assess the latter 395 
possibility, we used a pre-culture strategy to remove potential maternal Efa6 (see Methods for 396 
details; Prokop et al., 2012; Sánchez-Soriano et al., 2010). When plating neurons after 5 days 397 
of pre-culture, we still found a low amount of MT disorganisation in young neurons and a 398 
subsequent gradual increase to severe phenotypes over the following days (Figure 8J). 399 
This finding argues for a continued role of Efa6 in preventing MT disorganisation during 400 
development as well as in mature neurons. To further test this possibility, we used a 401 
temperature-based conditional knock-down technique (elav-GAL4 UAS-Efa6-RNAi UAS-402 
Gal80ts abbreviated to elav/Efa6IR/Gal80ts; see Methods for details): the elav/Efa6IR/Gal80ts 403 
neurons were grown without knock-down (19°C) for 3 days, a stage at which they have long 404 
undergone synaptic differentiation (Küppers-Munther et al., 2004); at that point, we found no 405 
difference in MT disorganisation between non-induced construct-bearing cells and control 406 
neurons (Figure 8K). After this period, cells were grown for another four days under knock-407 
down conditions (27°C), and then fixed on day seven. At this point, MT disorganisation in the 408 
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elav/Efa6IR/Gal80ts neurons was significantly increased over control neurons (Figure 8K), 409 
indicating that Efa6 is not only required during development but also during later maintenance 410 
to prevent MT disorganisation. 411 
In contrast to increased MT disorganisation upon functional loss of Efa6, expression of Efa6-412 
FL::GFP or Efa6-Nterm::GFP::CAAX showed a tendency to reduce MT disorganisation even 413 
below the baseline levels measured in control cells (cultured in parallel without the expression 414 
construct; Figure 8I), suggesting that also this role of Efa6 is likely due to the cortical collapse 415 
function of Efa6 (see Discussion).  416 
  417 
Efa6 maintains axonal MT bundle integrity in vivo 418 
We then assessed whether a role of Efa6 in MT bundle maintenance is relevant in vivo. For 419 
this, we studied a subset of lamina neurons, which project prominent axons in the medulla of 420 
the adult optic lobe (Prokop and Meinertzhagen, 2006). We labelled MTs in these axons by 421 
expressing -tubulin84B-GFP either alone (GMR-tub controls), or together with Efa6RNAi to 422 
knock down Efa6 specifically in these neurons (GMR-tub-Efa6IR; see Methods for details).  423 
When analysing aged flies at 26-27 days, we found that Efa6 knock-down caused a doubling 424 
in the occurrence of axonal swellings with disorganised axonal MTs: the average of total 425 
swellings per column section was increased from 0.3 in controls to 0.65 swellings upon Efa6 426 
knock-down; about a third of these contained disorganised MTs (GMR-tub-Efa6IR: 0.23 per 427 
column section; GMR-tub: 0.13; Figure 9). These data demonstrated that our findings in 428 
cultured neurons are relevant in vivo. 429 
We propose therefore that Efa6 provides a quality control mechanism that prevents MT 430 
disorganisation by inhibiting only MTs that have escaped axonal bundles. This model would 431 
also be consistent with the slow onset and gradual increase of MT disorganisation we 432 
observed upon Efa6 deficiency (Figure 8I,J). 433 
 434 
Efa6 and Shot promote MT bundles through complementary mechanisms  435 
If Efa6 provides a quality control mechanism that "cleans up" explorative MTs, it should act 436 
complementary to other factors that "prevent" explorative MTs by actively keeping them in 437 
axonal bundles. Important preventive factors in both mammals and fly are the spectraplakins 438 
(Bernier and Kothary, 1998; Dalpe et al., 1998; Voelzmann et al., 2017). In Drosophila, 439 
spectraplakins are represented by the single short stop (shot) gene; shot deficiency causes a 440 
severe increase in axonal off-track MTs and MT disorganisation (Alves-Silva et al., 2012; Qu 441 
et al., 2017; Sánchez-Soriano et al., 2009).  442 
To study potential mutual enhancement of Efa6 and shot mutant phenotypes, we first 443 
determined numbers of MTs in axonal shaft filopodia: both single-mutant conditions showed a 444 
strong enhancement of filopodial MTs (blue vs. orange bars in Figure 6F,G); this phenotype 445 
was substantially further increased in shot3 Efa6GX6[w-] double-mutant neurons (orange/blue 446 
bars in Figure 6F,G). Vice versa, when transfecting Efa6-FL-GFP to boost the hypothesised 447 
"cleaning-up" function, the shot3 mutant phenotype was significantly improved (Figure 6G). 448 
We then tested whether this increase in off-track MTs would correlate with more MT 449 
disorganisation. At 6 HIV, shot3 mutant neurons displayed a 2.4-fold, and Efa6GX6[w-] mutant 450 
neurons a 1.55-fold increase in MDI (normalised to wild-type); this value was dramatically 451 
increased to 6.16 fold in shot3 Efa6GX6[w-] double mutant neurons (Figure 8M). This suggests 452 
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that Efa6 and Shot do not act through the same mechanism, but perform complementary roles 453 
in regulating and maintaining axonal MTs and MT bundles. This conclusion was further 454 
confirmed by our finding that transfection of Efa6-FL-GFP into shot3 mutant neurons could 455 
alleviate the MDI phenotype (Figure 8N). 456 
Finally, we assessed whether these complementary relationships between Shot and Efa6 are 457 
relevant in vivo. Since complete loss of Shot is an embryonically lethal condition, we first 458 
tested in culture whether the lack of just one copy of shot has an enhancing effect on Efa6 459 
deficiency. We found that MT disorganisation phenotypes of Efa6-RNAi (blue bar in Figure 8L) 460 
and of shot3/+ heterozygous mutant neurons (orange bar) at 6 HIV were clearly enhanced 461 
when both genetic manipulations were combined (orange/blue bar). When testing the same 462 
genetic constellations in our optic lobe model, we found that the originally observed increase 463 
in MT disorganisation caused by cell-autonomous knock-down of Efa6 (black arrows and blue 464 
bar in Figure 9B,E) was also further enhanced when the same experiment was carried out in a 465 
shot3/+ heterozygous mutant background (black arrows and orange/blue bar in Figure 9C,E).  466 
These findings support our conclusion that there is a correlation between off-track MTs and 467 
MT disorganisation. Furthermore, they are consistent with a scenario where both Shot and 468 
Efa6 regulate axonal MTs but through independent and complementary pathways: Efa6 469 
inhibits MTs at the cortex (with peripheral MTs persisting for longer if Efa6 is absent), whereas 470 
Shot actively maintains MTs in bundles (with more MTs going off-track if Shot is absent) - and 471 
both these functions complement each other during MT bundle maintenance and enhance 472 
each other's mutant phenotypes in double-mutant conditions (see further details in the 473 
Discussion). 474 
 475 
Discussion 476 
 477 
Cortical collapse factors are important microtubule regulators relevant for axon morphology 478 
Axons are the structures that wire our brain and body and are therefore fundamental to 479 
nervous system function. To understand how axons are formed during development, can be 480 
maintained in a plastic state thereafter, and why they deteriorate in pathological conditions, we 481 
need to improve our knowledge of axonal cell biology (Salvadores et al., 2017; Sheng, 2017). 482 
The MT bundles that form the core of axons are an essential aspect of this cell biology, and 483 
understanding how these bundles are regulated and contribute to axon morphogenesis will 484 
provide essential insights into axon development and maintenance (Hahn et al., 2019; 485 
Voelzmann et al., 2016a). Here we have addressed fundamental contributions made by 486 
cortical collapse factors. We started from reports that two such factors from distinct protein 487 
families both negatively impact on axon growth in species as diverse as C. elegans (CeEfa6; 488 
Chen et al., 2015; Chen et al., 2011) and mouse (Kif21A; van der Vaart et al., 2013).  489 
We found that DmEfa6 likewise acts as a negative regulator of axon growth. We demonstrate 490 
that fly Efa6 is a cortical collapse factor, inhibiting MTs primarily via the 18aa long MTED. 491 
Since the MTED is the only shared motif with CeEfa6 in an otherwise entirely divergent N-492 
terminus (Figure 3C), this clearly demonstrates that the MTED is functionally conserved 493 
between both species (Chen et al., 2015; Chen et al., 2011; O'Rourke et al., 2010).  494 
Capitalising on Drosophila neurons as a conceptually well-established model for studies of 495 
axonal MT regulation (Hahn et al., 2019; Prokop et al., 2013), we went on to demonstrate two 496 
novel roles for Efa6: as a negative regulator of axon branching and a quality control factor 497 
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maintaining MT bundle organisation. To perform these functions, Efa6 does not affect the 498 
dynamics of MTs contained within the central axonal bundles, but it inhibits mainly those MTs 499 
that leave these bundles (Figure 10A). By inhibiting explorative MTs in GCs, it negatively 500 
impacts on a key event underlying axon growth (explained below; yellow arrows in Figure 501 
10C). By inhibiting off-track MTs in the axon shaft, it tones down the machinery that seeds 502 
new interstitial branches (red arrow in Figure 10C), but also prevents these MTs from going 503 
astray and cause MT disorganisation (curled MTs in Figure 10C).  504 
Therefore, our work provides conceptual understanding of cortical collapse factors, which can 505 
explain how their molecular functions and subcellular roles in MT regulation link to their 506 
reported axonal growth phenotypes during development and regeneration (Chen et al., 2015; 507 
Chen et al., 2011; Heidary et al., 2008; van der Vaart et al., 2013), and to their additional 508 
functions in axon branching and maintenance reported here. Apart from existing links of 509 
cortical collapse factors to neurodevelopmental disorders (Heidary et al., 2008; Tiab et al., 510 
2004; van der Vaart et al., 2013), we would therefore predict future links also to 511 
neurodegeneration.    512 
 513 
Roles of Efa6 during axonal growth 514 
During axon growth, MTs constantly polymerise towards the periphery of GCs; the advance of 515 
many of these MTs is inhibited at the leading edge, and our work shows that cortical collapse 516 
factors are key mediators to this end. Only a fraction of MTs enters filopodia, potentially 517 
helped by active guidance mechanisms such as MT-actin cross-linkage (e.g. through 518 
spectraplakins, tau, drebrin-EB3; Alves-Silva et al., 2012; Biswas and Kalil, 2018; Geraldo et 519 
al., 2008). The widely accepted protrusion-engorgement-consolidation model of axon growth 520 
proposes that stabilised MTs in filopodia can seed axon elongation events (Aletta and Greene, 521 
1988; Goldberg and Burmeister, 1986; Prokop et al., 2013). This model is consistent with our 522 
findings for Efa6. Thus loss of Efa6 can contribute to enhanced axon growth in two ways: 523 
firstly, through allowing more MTs to enter filopodia; secondly, by allowing them to dwell in 524 
filopodia for longer, thus enhancing the likelihood of their stabilisation (yellow arrows in Figure 525 
10C). This scenario can explain why loss of Efa6 in C. elegans improves axon re-growth after 526 
injury and growth overshoot during development (Chen et al., 2015; Chen et al., 2011), and 527 
why the upregulation of Kif21A levels in GCs causes stalled axon growth (van der Vaart et al., 528 
2013).  529 
In C. elegans it was shown that axonal injury leads to a re-localisation of CeEfa6 to MT minus 530 
ends at the core axons (Chen et al., 2015). None of the conditions used in our study 531 
reproduced such behaviour with fly Efa6. Furthermore, it was shown that such central pools of 532 
CeEfa6 require their MTED to recruit two kinases: TAC-1 (homologue of TACC/transforming-533 
acidic-coiled-coil) and ZYG-8 (homologue of DCLK/Doublecortin-Like-Kinase; Chen et al., 534 
2015). However, in contrast to Efa6, both of these kinases perform growth-enhancing 535 
functions and play a secondary, delayed role downstream of Efa6. They are therefore 536 
unsuited to explain the direct MT-inhibiting roles of the MTED (Figure 4). In contrast, virtually 537 
all structure-function analyses performed with CeEfa6 in developing and regenerating axons 538 
perfectly match our data and can be explained through our proposed model. Based on our 539 
findings, one might argue that CeEfa6 detachment from the membrane (Chen et al., 2015) 540 
could be the consequence of injury-induced physiological changes that would then pose a 541 
threat to axonal MT bundles; localisation to MT minus ends could therefore represent a 542 
protective sequestration mechanism. Another C. elegans study reported that loss of Efa6 has 543 
no impact on MT length in developing axons (Yogev et al., 2016), which appears consistent 544 
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with our data (Figure 6A-D). They also found an increase in MT numbers, but there is 545 
currently no mechanism to explain this in non-injury conditions where CeEfa6 stays at the 546 
membrane (Chen et al., 2015).  547 
Interestingly, also mammalian Efa6 plays a role in axon regeneration. However, this 548 
mechanism is entirely different, in that it requires the C-terminus to activate Arf6 which, in turn, 549 
regulates integrin trafficking at the axon initial segment (Eva et al., 2017). 550 
 551 
Roles of Efa6 during axonal branching 552 
Axon branching can occur via GC split, in that diverging MTs get stabilised in parallel in the 553 
same GC (Acebes and Ferrus, 2000; yellow arrows in Figure 10C). Alternatively, it can occur 554 
through interstitial branching which involves the active generation (e.g. through MT severing) 555 
and then stabilisation of off-track MTs (Kalil and Dent, 2014; Lewis et al., 2013; Tymanskyj et 556 
al., 2017; Yu et al., 2008). Both models agree with our observations in Efa6-deficient/over-557 
expressing neurons: we find greater/lower numbers of MTs in GC and shaft filopodia at 6 HIV, 558 
which then correlate with enhanced/reduced axonal branch numbers in mature neurons (red 559 
arrow in Figure 10C).  560 
If interstitial branch formation is negatively regulated by Efa6, this poses the question as to 561 
whether Efa6 has to be actively down-regulated in healthy neurons for branching to occur. 562 
Efa6 could either be physically removed from future branch points (Chen et al., 2015) or its 563 
MT inhibition function could be switched off. However, in our view, no such regulation is 564 
required because Efa6 seems to be in a well-balanced equilibrium. Enough Efa6 appears to 565 
be present to inhibit occasional, likely accidental off-track MTs; this capacity is surpassed 566 
when the number of off-track MTs is actively increased, for example through MT severing 567 
proteins during axonal branch formation (Yu et al., 2008). Such a saturation model is 568 
supported by our experiments with shot (Figure 6F,G): filopodial MT numbers are elevated in 569 
shot mutant neurons, although Efa6 is present and functional (as demonstrated by the further 570 
increase in filopodial MT numbers in shot Efa6 double-mutant neurons; Figure 10D,E). This is 571 
consistent with a model where Efa6 function occurs at a level that is easily saturated when 572 
increasing the number of explorative MTs. Such a view would also explain why loss of CeEfa6 573 
promotes axon regeneration in C. elegans (Chen et al., 2015; Chen et al., 2011), in that the 574 
constant base-line of MT inhibition present in the wild-type, is removed in the mutant 575 
condition, thus favouring growth-mediating explorative MTs. 576 
 577 
Roles of Efa6 during axonal MT bundle maintenance 578 
Axonal MT disorganisation in Efa6-deficient neurons occurs gradually and can even be 579 
induced by knock-down of Efa6 at mature stages (Figure 8K). Therefore, Efa6 appears to 580 
prevent MT disorganisation during axon development and maintenance, as is consistent with 581 
its continued expression in the nervous system (Figure 1). Such a continued role makes 582 
sense in a scenario where MT bundles remain highly dynamic throughout a neuron's lifetime, 583 
constantly undergoing polymerisation to drive renewal processes that prevent senescence 584 
(Hahn et al., 2019; Voelzmann et al., 2016a). 585 
Based on these findings, we propose Efa6 to act as a quality control or maintenance factor 586 
within our model of "local axon homeostasis" (Hahn et al., 2019; Prokop, 2016). This model 587 
states that MTs in the force-enriched environment of axons have a tendency to go off-track 588 
and curl up (Pearce et al., 2018), thus potentially seeding MT disorganisation. Different 589 
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classes of MT-binding regulators, amongst them spectraplakins, prevent this by actively 590 
promoting the bundled conformation (Hahn et al., 2019). We propose that cortical collapse 591 
factors act complementary to spectraplakins in that they play no role in maintaining MTs in 592 
bundles, but they inhibit those MTs that have escaped the bundling mechanisms (Hahn et al., 593 
2019). 594 
In this scenario, MTs are protected from cortical collapse as long as they are actively 595 
maintained in axonal bundles; this can explain the long known conundrum of how axonal MTs 596 
extend hundreds of micrometres in relative proximity to the cell cortex in axons, whereas in 597 
non-neuronal cells cortical proximity of MTs tends to trigger either their inhibition or tethered 598 
stabilisation (Fukata et al., 2002; Kaverina et al., 1998).  599 
  600 
Evolutionary and mechanistic considerations of Efa6 function 601 
We found that the MTED motif correlates well with MT inhibiting functions of Efa6 family 602 
members, whereas the rest of the N-terminus bears no obvious further reminiscence. Our 603 
experiments with N-terminal protein and synthetic MTED peptide, both reveal association with 604 
MTs/tubulin. The MTED strongly interferes with MT polymerisation. Future co-crystallisation 605 
experiments are required to reveal how the MTED works. Given its small size we hypothesise 606 
that it simply blocks assembly, rather than acting via more complex mechanisms such as 607 
active promotion of depolymerisation (e.g. kinesin-8 and -13, XMap215; Al-Bassam and 608 
Chang, 2011; Brouhard and Rice, 2014) or severing (e.g. spastin, katanin, fidgetin; McNally 609 
and Roll-Mecak, 2018; Sharp and Ross, 2012).  610 
In any case, the small size of MTEDs might come in handy as experimental tools to inhibit 611 
MTs, potentially displaying complementary properties to existing genetic tools such as the 612 
kinesin-13 Kif2C (Moore et al., 2005; Schimizzi et al., 2010), stathmin (Marklund et al., 1996) 613 
or spastin (Eckert et al., 2012). Importantly, the experiments with the CAAX domain have 614 
shown that Efa6's MT inhibiting function can be targeted to specific subcellular compartments 615 
to clear them of MTs, thus opening up a wide range of future applications. 616 
Interestingly, the MT-inhibiting role of Efa6 seems not to be conserved in chordates when 617 
taking the MTED as indicator for this function ( Figure 3-figure supplement 4A). However, 618 
roles of cortical collapse factors in neurons seem to have been taken over by other proteins 619 
such as the kinesin-4 family member Kif21A. The CFEOM1-linked Kif21AR954W mutation 620 
causes the protein to relocate from the axon shaft to the growth cone of cultured hippocampal 621 
neurons (van der Vaart et al., 2013). In consequence, increased Kif21A levels in GCs cause 622 
reduced axon growth - and we observed the same with Efa6 over-expression (green bars in 623 
Figure 2D). The decreased levels of Kif21A in proximal axons correlate with a local increase in 624 
side branches - and we observed the same with Efa6 loss of function (blue bars in Figure 625 
7E,L).  626 
Finally, we found that the C-terminal domains of Efa6 might display some degree of functional 627 
conservation. So far, work on mammalian PSDs has revealed functions for C-terminal 628 
domains in regulating ARF6, ARF1 or ARL14 during actin cytoskeletal reorganisation and 629 
membrane ruffling, tumour formation, axon regeneration and immune regulation (Derrien et 630 
al., 2002; Eva et al., 2017; Paul et al., 2011; Pils et al., 2005). Our finding that PSD1 and C-631 
terminal Efa6 constructs cause similar membrane ruffling phenotypes in fibroblasts (Figure 3-632 
figure supplements 6 and 7), suggests that some conserved functions reside in this region and 633 
might further contribute, together with N-terminally mediated MT inhibition, to the neuronal or 634 
non-neuronal defects that cause semi-lethality displayed by Efa6 mutant flies (data not 635 
Qu et al. – The role of Efa6 in axon maintenance  15 
 
shown).  636 
 637 
Conclusions and future perspectives 638 
We propose that Efa6 acts as a cortical collapse factor which is important for the regulation of 639 
axonal MTs and relevant for axon growth, maintenance and branching. Although this function 640 
of Efa6 is evolutionarily not widely conserved, our findings provide a helpful paradigm for 641 
studies of other classes of cortical collapse factors also in mammalian neurons. Promising 642 
research avenues will be to refine our mechanistic understanding of how Efa6 blocks MT 643 
polymerisation, not only to better understand how it can be regulated in axons, but also to 644 
better exploit MTEDs as molecular tools in cell biological research.  645 
 646 
Materials and methods 647 
 648 
Fly stocks  649 
Loss-of-function mutant stocks used in this study were the two deficiencies uncovering the 650 
Efa6 locus Df(3R)Exel6273 (94B2-94B11 or 3R:22,530,780..22,530,780; RRID:BDSC_7740) 651 
and Df(3R)ED6091 (94B5-94C4 or 3R:22,587,681..22,587,681; RRID:DGGR_150165): shot3 652 
(the strongest available allele of short stop; Kolodziej et al., 1995; Sánchez-Soriano et al., 653 
2009; RRID:BDSC_5141); Efa6KO#1 (ends-out targeting mutant that contains a small 74-bp 654 
deletion in exon 8) and three null alleles generated as genomic engineering intermediates: the 655 
knock-out founder line Efa6GX6[w+] and the two founder lines Efa6GX6[w-] (RRID:BDSC_60587 ) 656 
and Arf51FGX16[w-] (RRID:BDSC_60585; all published in Huang et al., 2009). Gal4 driver lines 657 
used were the pan-neuronal lines sca-Gal4 (strongest in embryos; Sánchez-Soriano et al., 658 
2010) and elav-Gal4 (1st and 3rd chromosomal, both expressing at all stages; 659 
RRID:DGGR_105921, RRID:BDSC_8760; Luo et al., 1994), GMR31F10-Gal4 (Bloomington 660 
#49685; RRID:BDSC_49685), as well as the ato-Gal4 line expressing in a subset of neurons 661 
in the adult brain (Hassan et al., 2000; Voelzmann et al., 2016b; RRID:DGGR_108799). Lines 662 
for targeted gene expression were UAS-Efa6RNAi (VDRC #42321; 663 
RRID:FlyBase_FBst0464531), UAS-Gal80ts (Zeidler et al., 2004), UAS-Eb1-GFP (Alves-Silva 664 
et al., 2012), UAS-GFP--tubulin84B (Grieder et al., 2000) and UAS-myr-tdTomato 665 
(Zschätzsch et al., 2014; RRID:BDSC_32222). Efa6 expression was detected via the 666 
genomically engineered Efa6-GFP allele, where a GFP was inserted after the last amino acid 667 
in exon 14 (Huang et al., 2009). 668 
Drosophila primary cell culture  669 
Drosophila primary neuron cultures were performed as published previously (Prokop et al., 670 
2012). In brief, stage 11 embryos were treated for 1 min with bleach to remove the chorion, 671 
sterilized for ~30 s in 70% ethanol, washed in sterile Schneider’s/FCS, and eventually 672 
homogenized with micro-pestles in 1.5 centrifuge tubes containing 21 embryos per 100 μl 673 
sterile filtered dispersion medium [167 ml distilled water, 30 ml Hanks' Balanced Salt Solution 674 
without calcium or magnesium (Gibco), 3 ml penicillin-streptomycin-solution (10,000 units; 675 
Gibco), 0.01g phenyl-thio urea (Sigma), 0.5 mg/ml collagenase type 1 (Worthington, 676 
Cellsystems) and 2 mg/ml Dispase (Roche)] and left to incubate for 5 min at 37°C. Cells are 677 
washed with Schneider’s medium (Gibco), spun down for 4 mins at 650 g, supernatant was 678 
removed and cells re-suspended in 90 µl of Schneider’s medium containing 20% fetal calf 679 
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serum (Gibco). 30 μl drops were placed on cover slips. Cells were allowed to adhere for 90-680 
120 min either directly on glass or on cover slips coated with a 5 µg/ml solution of 681 
concanavalin A, and then grown as a hanging drop culture for hours or days at 26°C as 682 
indicated. 683 
To abolish maternal rescue of mutants, i.e. masking of the mutant phenotype caused by 684 
deposition of normal gene product from the healthy gene copy of the heterozygous mothers in 685 
the oocyte (Prokop, 2013b), we used a pre-culture strategy (Prokop et al., 2012; Sánchez-686 
Soriano et al., 2010) where cells were kept for 5 days in a tube before they were re-dispersed 687 
and plated on a coverslip. 688 
For the transfection of Drosophila primary neurons, a quantity of 70-75 embryos per 100 μl 689 
dispersion medium was used. After the washing step and centrifugation, cells were re-690 
suspended in 100 μl transfection medium [final media containing 0.1-0.5 μg DNA and 2 μl 691 
Lipofecatmine 2000 (L2000)]. To generate this media, dilutions of 0.1-0.5 μg DNA in 50 μl 692 
Schneider's medium and 2 μl L2000 in 50 μl Schneider's medium were prepared, then mixed 693 
together and incubated at room temperature for 5-30 mins, before being added to the cells in 694 
centrifuge tubes where they were kept for 24 hrs at 26°C. Cells were then treated again with 695 
dispersion medium, re-suspended in culture medium and plated out as described above.  696 
For temporally controlled knock-down experiments we used flies carrying the driver construct 697 
elav-Gal4, the knock-down construct UAS-Efa6-RNAi, and the temperature-sensitive Gal4 698 
inhibitor UAS-Gal80ts, all in parallel. At the restrictive temperature of 19°C, Gal80ts blocks 699 
Gal4-induced expression of Efa6-RNAi, and this repressive action is removed at the 700 
permissive temperature of 27°C where Gal80ts is non-functional. Control neurons were from 701 
flies carrying only the Gal4/Gal80 (control 1 in Figure 8K) or only the Efa6-RNAi transgene 702 
(control 2). 703 
 704 
Fibroblast cell culture 705 
 NIH/3T3 mouse fibroblast cells (ATCC; RRID:CVCL_0594) were grown in DMEM 706 
supplemented with 1% glutamine (Invitrogen), 1% penicillin/streptomycin (Invitrogen) and 10% 707 
FCS in culture dishes (100 mm with vents; Fisher Scientific UK Ltd) at 37°C in a humidified 708 
incubator at 5% CO2. Cell lines have been tested for mycoplasma and are free of 709 
contamination. Cells were split every 2-3 d, washed with pre-warmed PBS, incubated with 4 710 
ml of Trypsin-EDTA (T-E) at 37°C for 5 min, then suspended in 7 ml of fresh culture medium 711 
and eventually diluted (1/3-1/20 dilution) in a culture dish containing 10 ml culture media. 712 
 For transfection of NIH/3T3 cells, 2 ml cell solution (~105 cells per ml) were first 713 
transferred to 6-well plates, and grown overnight to double cell density. 2 µg of DNA and 2 µl 714 
Plus reagent (Invitrogen) were added to 1 ml serum-free media in a centrifuge tube, incubated 715 
for 5 mins at RT, then 6 µl Lipofectamine (Invitrogen) were added, and incubated at RT for 25 716 
mins. Cells in the 6-well plate were washed with serum-free medium and 25 mins later 717 
DNA/Lipofectamine was mixed into the medium (1/1 dilution). Plates were incubated for 3 hrs 718 
at 37°C, washed with 2 ml PBS, 400 µl trypsin were added for 5 mins (37C), then 3 ml 719 
complete medium; cells were suspended and added in 1 ml aliquots to 35 mm glass-bottom 720 
dishes (MatTek) coated with fibronectin [300 µl of 5 µg/ml fibronectin (Sigma-Aldrich) placed 721 
in the center of a MatTek dish for 1 hr at 37°C, then washed with PBS]; 1 ml of medium was 722 
added and cells grown for 6 hrs or 24 hrs at 37°C in a CO2 incubator. For live imaging, the 723 
medium was replaced with 2 ml Ham’s F-12 medium + 4% FCS.  724 
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 725 
Dissection of adult brains 726 
To analyse the function of Efa6 in MT bundle integrity in medulla axons in vivo, flies were 727 
aged at 29°C. Flies were maintained in groups of up to 20 flies of the same gender (Stefana et 728 
al., 2017) and changed into new tubes every 3-4 days. Brain dissections were performed in 729 
Dulbecco's PBS (Sigma, RNBF2227) after briefly sedating them on ice. Dissected brains with 730 
their laminas and eyes attached were placed into a drop of Dulbecco's PBS on MatTek glass 731 
bottom dishes (P35G1.5-14C), covered by coverslips and immediately imaged with a 3i 732 
Marianas Spinning Disk Confocal Microscope.  733 
To measure branching in ato-Gal4 Drosophila neurons, adult brains were dissected in 734 
Dulbecco's PBS and fixed with 4% PFA for 15 min. Antibody staining and washes were 735 
performed with PBT (PBS supplemented with 0.3% Triton X-100). Specimens were embedded 736 
in Vectashield (VectorLabs). 737 
 738 
Immunohistochemistry 739 
Primary fly neurons and fibroblasts were fixed in 4% paraformaldehyde (PFA) in 0.05 M 740 
phosphate buffer (PB; pH 7–7.2) for 30 min at room temperature (RT); for anti-Eb1 staining, 741 
ice-cold +TIP fix (90% methanol, 3% formaldehyde, 5 mM sodium carbonate, pH 9; stored at -742 
80°C and added to the cells; Rogers et al., 2002) was added for 10 mins. Adult brains were 743 
dissected out of their head cases in PBS and fixed with 4% PFA in PBS for 1 hr, followed by a 744 
1hr wash in PBT. 745 
 Antibody staining and washes were performed with PBT. Staining reagents: anti-746 
tubulin (RRID:AB_477593, clone DM1A, mouse, 1:1000, Sigma; alternatively, 747 
RRID:AB_2210391, clone YL1/2, rat, 1:500, Millipore Bioscience Research Reagents); anti-748 
DmEb1 (gift from H. Ohkura; rabbit, 1:2000; Elliott et al., 2005); anti-Elav (mouse, 1:1000, 749 
DSHB, RRID:AB_528218); anti-GFP (ab6673, goat, 1:500, Abcam, RRID:AB_305643); Cy3-750 
conjugated anti-HRP (goat, 1:100, Jackson ImmunoResearch); F-actin was stained with 751 
Phalloidin conjugated with TRITC/Alexa647, FITC or Atto647N (1:100 or 1:500; Invitrogen and 752 
Sigma). Specimens were embedded in ProLong Gold Antifade Mountant. 753 
 754 
Microscopy and data analysis 755 
Standard documentation was performed with AxioCam monochrome digital cameras (Carl 756 
Zeiss Ltd.) mounted on BX50WI or BX51 Olympus compound fluorescent microscopes. For 757 
the analysis of Drosophila primary neurons, we used two well-established parameters (Alves-758 
Silva et al., 2012; Sánchez-Soriano et al., 2010): axon length (from cell body to growth cone 759 
tip; measured using the segmented line tool of ImageJ) and the degree of MT disorganisation 760 
in axons which was either measured as binary score or ratio (percentage of neurons showing 761 
obvious MT disorganisation in their axons) or as "MT disorganisation index" (MDI; Qu et al., 762 
2017): the area of disorganisation was measured using the freehand selection in ImageJ; this 763 
value was then divided by axon length (see above) multiplied by 0.5 μm (typical axon diameter, 764 
thus approximating the expected area of the axon if it were not disorganised). For Eb1::GFP 765 
comet counts, neurons were subdivided into axon shaft and growth cones (GC): the proximal 766 
GC border was set where the axon widens up (broader GCs) or where filopodia density 767 
increases significantly (narrow GCs). MT loss in fibroblasts was assessed on randomly 768 
chosen images of successfully transfected, GFP-expressing fibroblasts, stained for tubulin 769 
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and actin.  Due to major differences in plasma membrane versus cytoplasmic localisation of 770 
constructs, their expression strengths could not be standardised. Assuming a comparable 771 
expression strength distribution, we therefore analyse all transfected cells in the images and 772 
assigned them to three categories: 'MTs normal', 'MTs damaged' or "prominient MT networks 773 
gone" (Figure 3G-G’’). To avoid bias, image analyses were performed blindly, i.e. the 774 
genotype or treatment of specimens was masked. To analyse ruffle formation in fibroblasts, 775 
cells were stained with actin and classified (with or without ruffles).  776 
 To assess the degree of branching, we measured axonal projections of dorsal cluster 777 
neurons in the medulla, which is part of the optic lobe in the adult brain (Hassan et al., 2000; 778 
Voelzmann et al., 2016b). These neurons were labelled by expressing UAS-myr-tdTomato via 779 
the ato-Gal4 driver either alone (control), together with UAS-Efa6RNAi or together with UAS-780 
Efa6-FL-GFP. We analysed them in young brains (2-5 d after eclosure of flies from their pupal 781 
case) or old brains (15-18 d). Z-stacks of adult fly brains (optic lobe area) were taken with a 782 
Leica DM6000 B microscope and extracted with Leica MM AF Premier software. They were 783 
imaged from anterior and the number of branches was quantified manually. Branches were 784 
defined as the protrusions from the DC neuron axons in the medulla. Branches in fly primary 785 
neurons at 5DIV were also counted manually and defined as MT protrusions from main axon. 786 
 To measure MT disorganisation in the optic lobe of adult flies, GMR31F10-Gal4 787 
(Bloomington #49685) was used to express UAS-GFP--tubulin84B (Grieder et al., 2000) in a 788 
subset of lamina axons which projects within well-ordered medulla columns (Prokop and 789 
Meinertzhagen, 2006). Flies were left to age for 26-27 days (about half their life expectancy) 790 
and then their brains were dissected out, mounted in MatTek dishes and imaged using a 3i 791 
spinning disk confocal system at the ITM Biomedical imaging facility at the University of 792 
Liverpool. A section of the medulla columns comprising the 4 most proximal axonal terminals 793 
was used to quantify the number of swellings and regions with disorganised MTs. 794 
 Time lapse imaging of cultured primary neurons (in Schneider's/FCS) and fibroblasts 795 
(in Ham’s F-12/FCS) was performed on a Delta Vision Core (Applied Precision) restoration 796 
microscope using a [100x/1.40 UPlan SAPO (Oil)] objective and the Sedat Quad filter set 797 
(Chroma #89000). Images were collected using a Coolsnap HQ2 (Photometrics) camera. The 798 
temperature was set to 26°C for fly neurons and 37°C for fibroblasts. Time lapse movies were 799 
constructed from images taken every 2 s for 2 mins. To analyse MT dynamics, Eb1::GFP 800 
comets were tracked manually using the “manual tracking” plug-in of ImageJ. 801 
 Images were derived from at least 2 independent experimental repeats performed on 802 
different days, for each of which at least 3 independent culture wells were analysed by taking 803 
a minimum of 20 images per well. For statistical analyses, Kruskal–Wallis one-way ANOVA 804 
with post hoc Dunn’s test or Mann–Whitney Rank Sum Tests (indicated as PMW) were used to 805 
compare groups, and χ2 tests (indicated as PX2) were used to compare percentages. All raw 806 
data of our analyses are provided as supplementary Excel/Prism files. 807 
 808 
Molecular biology 809 
EGFP tags are based on pcDNA3-EGFP (RRID:Addgene_13031 ) or pUAST-EGFP. All 810 
Drosophila melanogaster efa6 constructs are based on cDNA clone IP15395 (Uniprot isoform 811 
C, intron removed). Caenorhabditis elegans efa-6 (Y55D9A.1a) constructs are derived from 812 
pCZGY1125-efa-6-pcr8 (kindly provided by Andrew Chisholm). Homo sapiens PSD1 813 
(ENST00000406432.5, isoform 202) constructs were PCR-amplified from pLC32-hu-psd1-814 
pcr8 vector (kindly provided by Andrew Chisholm). Homo sapiens PSD2 815 
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(ENST00000274710.3, isoform 201, 771aa) constructs were PCR-amplified from pLC33-hu-816 
psd2-pcr8 vector (kindly provided by Andrew Chisholm). Homo sapiens PSD3 was PCR-817 
amplified from pLC34 hu-psd3-pcr8 vector (kindly provided Andrew Chisholm). Note that the 818 
PSD3 cDNA clone is most closely related to isoform 201 (ENST00000286485.12: 513aa) and 819 
therefore lacks the putative N-terminus found in isoform 202 (ENST00000327040.12). 820 
However, the putative MTED core sequence is encoded in the C-terminal PH domain (orange 821 
in Figure 3C), not the potential N-terminus. Homo sapiens PSD4 (ENST00000441564.7, 822 
isoform 205) was PCR-amplified from pLC35-hu-psd4-pcr8 vector (kindly provided by Andrew 823 
Chisholm). The CAAX motif is derived from human KRAS. The DmEfa6-Nterm∆SxiP::EGFP 824 
(aa1-410) insert was synthesised by GeneArt Express (ThermoFisher). All construct were 825 
cloned using standard (SOE) PCR/ligation based methods, and constructs and inserts are 826 
detailed in Table T1. To generate transgenic fly lines, P[acman]M-6-attB-UAS-1-3-4 827 
constructs were integrated into PBac{yellow[+]-attP-3B}VK00031 (Bloomington line #9748; 828 
RRID:BDSC_9748) via PhiC31 mediated recombination (outsourced to Bestgene Inc.). 829 
 830 
final vector Source insert 
pcDNA3-EGFP Addgene XhoI-EGFP-XbaI 
pUAST-AscI-PacI-EGFP  this study KpnI, AscI, PacI-EGFP-XbaI 
pUAST-DmEfa6FL-EGFP (aa1-1387) this study 
KpnI, AscI-kozak-Efa6 (aa1-1387)-GSGSGS-
EGFP-PacI, XbaI 
P[acman]M-6-attB-UAS-1-3-4-
DmEfa6FL-EGFP (aa1-1387) 
this study AscI-kozak-DmEfa6 (aa1-1387)-GSGSGS-
EGFP-PacI 
pcDNA3.1-DmEfa6FL-EGFP (aa1-
1387) 
this study KpnI, AscI-kozak-DmEfa6 (aa1-1387)-
GSGSGS-EGFP-PacI, XbaI 
pUAST-DmEfa6∆Cterm-EGFP (aa1-
894) 
this study KpnI, AscI-kozak-DmEfa6∆Cterm (aa1-894)-
GSGSGS-EGFP-PacI, XbaI 
P[acman]M-6-attB-UAS-1-3-4-
DmEfa6∆Cterm-EGFP (aa1-894) 
this study AscI-kozak-DmEfa6∆Cterm (aa1-894)-
GSGSGS-EGFP-PacI 
pcDNA3.1-DmEfa6∆Cterm-EGFP 
(aa1-894) 
this study KpnI, AscI-kozak-DmEfa6∆Cterm (aa1-894)-
GSGSGS-EGFP-PacI, XbaI 
pUAST-DmEfa6-Nterm-EGFP (aa1-
410) 
this study KpnI, AscI-kozak-DmEfa6-Nterm (aa1-410)-
GSGSGS-EGFP-PacI, XbaI 
P[acman]M-6-attB-UAS-1-3-4-
DmEfa6-Nterm-EGFP (aa1-410) 
this study AscI-kozak-DmEfa6-Nterm (aa1-410)-
GSGSGS-EGFP-PacI 
pcDNA3.1-DmEfa6-Nterm-EGFP 
(aa1-410) 
this study KpnI, AscI-kozak-DmEfa6-Nterm (aa1-410)-
GSGSGS-EGFP-PacI, XbaI 
pUAST-DmEfa6-Nterm-CAAX-EGFP 
(aa1-410) 
this study KpnI, AscI-kozak-DmEfa6-Nterm (aa1-410)-
GSGSGS-EGFP-CAAX[KRAS]-PacI, XbaI 
P[acman]M-6-attB-UAS-1-3-4-
DmEfa6-Nterm-CAAX-EGFP (aa1-
410) 
this study 
AscI-kozak-DmEfa6-Nterm (aa1-410)-
GSGSGS-EGFP-CAAX[KRAS]-PacI 
pcDNA3.1-DmEfa6-Nterm-CAAX-
EGFP (aa1-410) 
this study KpnI, AscI-kozak-DmEfa6-Nterm (aa1-410)-
GSGSGS-EGFP-CAAX[KRAS]-PacI, XbaI 
pUAST-DmEfa6-Nterm∆SxiP-EGFP 
(aa1-410) 
this study KpnI, AscI-kozak-DmEfa6-Nterm∆SxiP (aa1-
410; SQIP>AAAA; SRIP>AAAA)-GSGSGS-
EGFP-PacI, XbaI 
pcDNA3.1-DmEfa6-Nterm∆SxiP-
EGFP (aa1-410) 
this study KpnI, AscI-kozak-DmEfa6-Nterm∆SxiP (aa1-
410; SQIP>AAAA; SRIP>AAAA)-GSGSGS-
EGFP-PacI, XbaI 
pUAST-DmEfa6-Nterm∆MTED-
EGFP (aa1-300) 
this study KpnI, AscI-kozak-DmEfa6-Nterm∆MTED (aa1-
300)-GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-DmEfa6-Nterm∆MTED-
EGFP (aa1-300) 
this study KpnI, AscI-kozak-DmEfa6-Nterm∆MTED (aa1-
300)-GSGSGS-EGFP-PacI, XbaI 
pUAST-DmEfa6∆Nerm-EGFP 
(aa851-1387) 
this study KpnI, AscI-kozak-DmEfa6∆Nerm (aa851-1387)-
GSGSGS-EGFP-PacI, XbaI 
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pcDNA3.1-DmEfa6∆Nerm-EGFP 
(aa851-1387) 
this study KpnI, AscI-kozak-DmEfa6∆Nerm (aa851-1387)-
GSGSGS-EGFP-PacI, XbaI 
pUAST-DmEfa6-MTED-EGFP 
(aa322-341) 
this study KpnI, AscI-kozak-DmEfa6-MTED (aa322-341)-
GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-DmEfa6-MTED-EGFP 
(aa322-341) 
this study KpnI, AscI-kozak-DmEfa6-MTED (aa322-341)-
GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-CeEfa6-FL-EGFP (aa1-
816) 
this study KpnI, AscI-kozak-CeEfa6 (aa1-816)-GSGSGS-
EGFP-PacI, XbaI 
pcDNA3.1-CeEfa6-Nterm-EGFP 
(aa1-152) 
this study KpnI, AscI-kozak-CeEfa6-Nterm (aa1-152)-
GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-CeEfa6-MTED-EGFP 
(aa24-42) 
this study KpnI, AscI-kozak-CeEfa6-MTED (aa24-42)-
GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-HsPSD1-FL-EGFP (aa1-
1024) 
this study KpnI, AscI-kozak-HsPSD1 (aa1-1024)-
GSGSGS-NotI-EGFP-PacI, XbaI 
pcDNA3.1-HsPSD1-Nterm-EGFP 
(aa1-280) 
this study KpnI, AscI-kozak-HsPSD1-Nterm (aa1-280)-
GSGSGS-NotI-EGFP-PacI, XbaI 
pcDNA3.1-HsPSD1-MTED-EGFP 
(aa31-49) 
this study KpnI, AscI-kozak-HsPSD1-MTED (aa31-49)-
GSGSGS-NotI-EGFP-PacI, XbaI 
pcDNA3.1-HsPSD2-FL-EGFP (aa1-
771) 
this study KpnI, AscI-kozak-HsPSD2 (aa1-771)-GSGSGS-
NotI-EGFP-PacI, XbaI 
pcDNA3.1-HsPSD3-EGFP (aa515-
1047) 
this study KpnI, AscI-kozak-HsPSD3 (aa515-1047)-
GSGSGS-NotI-EGFP-PacI, XbaI 
pcDNA3.1-HsPSD4-FL-EGFP (aa1-
1027) 
this study KpnI, AscI-kozak-HsPSD4 (aa1-1027)-
GSGSGS-NotI-EGFP-PacI, XbaI 
pcDNA3.1-co-HsPSD1-MTED-EGFP 
(aa31-49) 
this study KpnI, AscI-kozak-HsPSD1-MTED (aa31-49)-
GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-co-CeEfa6-MTED-EGFP 
(aa24-42) 
this study KpnI, AscI-kozak-CeEfa6-MTED (aa24-42)-
GSGSGS-EGFP-PacI, XbaI 
pcDNA3.1-co-DmEfa6-MTED-EGFP 
(aa322-341) 
this study KpnI, AscI-kozak-DmEfa6-MTED (aa322-341)-
GSGSGS-EGFP-PacI, XbaI 
pCS107-DmEfa6-Nterm-EGFP 
this study NotI-kozak-DmEfa6-Nterm (aa1-410)-GSGSGS-
EGFP-StuI 
pFastBac-His6-MCAK-EGFP-StrepII not known His6-MCAK::EGFP-StrepII 
pFastBac-His6-DmEfa6∆Cterm-
EGFP-StrepII (aa1-894) 
this study His6-DmEfa6∆Cterm::EGFP-StrepII (aa1-894) 
Table 1. Constructs and inserts used to generate expression and transgenic constructs.  The 831 
left column lists the final vector representing intermediate steps of cloning procedures or 832 
vectors employed for experiments on this study, the middle column the source of the vectors, 833 
and the right column the inserts of vectors on the left. Abbreviations: co=codon optimised; 834 
Dm=Drosphila melanogaster; Ce=Caenorhabditis elegans; Hs=Homo sapiens  835 
 836 
In silico analyses 837 
To generate the phylogenetic tree of Efa6/PSD full length isoforms and N-terms of different 838 
species (see Figure 3-figure supplement 5), their amino acid sequences were aligned using 839 
Muscle or ClustalO (Goujon et al., 2010; McWilliam et al., 2013; Sievers et al., 2011). ProtTest 840 
(Abascal et al., 2005; Darriba et al., 2011) was used to determine amino acid frequencies in 841 
the protein datasets and to identify the optimal amino acid substitution model to be used for 842 
the Bayesian inference (VT+I+G+F). CUDA-Beagle-optimised MrBayes (Ronquist et al., 2012) 843 
was run using the VT+I+G+F model [prset statefreqpr=fixed(empirical); lset rates=invgamma] 844 
using 5 chains (1 heated) and 9 parallel runs until the runs converged and standard deviation 845 
of split frequencies were below 0.015 (0.06 for N-terms); PSRF+ was 1.000 and min ESS 846 
was >1300 for the TL, alpha and pinvar parameters. The Drosophila melanogaster Sec7-PH 847 
domain-containing protein Steppke was used as outgroup in the full length tree. 848 
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Archaeopteryx (Han and Zmasek, 2009) was used to depict the MrBayes consensus tree 849 
showing branch lengths (amino acid substitutions per site) and Bayesian posterior 850 
probabilities. 851 
 To identify a potential MTED in PSD1, previously identified Efa6 MTED motifs 852 
(O'Rourke et al., 2010) of 18 orthologues were aligned to derive an amino acid logo. Further 853 
orthologues were identified and used to refine the logo. Invariant sites and sites with restricted 854 
amino acid substitutions were determined (most prominently MxG-stretch). Stretches 855 
containing the invariant MxG stretch were aligned among vertebrate species to identify 856 
potential candidates. Berkley’s Weblogo server (Crooks et al., 2004) was used to generate 857 
amino acid sequence logos for each phylum using MTED (ExxxMxGE/D) and MTED-like 858 
(MxGE/D) amino acid stretches. 859 
 860 
In vitro analyses  861 
Protein Expression and Purification: Drosophila Efa6-ΔCterm was cloned into a modified 862 
pFastBac vector containing an N-terminal His6 tag and C-terminal eGFP and StrepII tags. 863 
Recombinant protein was expressed in Sf9 insect cells for 72 hours using a Baculovirus 864 
system. The protein was purified via a two-step protocol of Ni-affinity using a 1ml His-Trap 865 
column (GE Healthcare) in Ni-affinity buffer [50 mM Tris pH 7.5, 300 mM NaCl, 1mM Mg Cl2, 866 
10 % (v/v) glycerol] and elution with 200mM imidazole, followed by Step-tag affinity 867 
chromatography using StepTactin resin (GE Healthcare) in BRB20, 75mM KCl. 0.1% Tween 868 
20, 10% (v/v) glycerol and elution in the same buffer with 5mM desthiobiotin. MTED peptide 869 
(Genscript) was shipped as lyophilised powder with a purity of 95.2%. Upon arrival peptide 870 
was dissolved in ultrapure water and used directly. 871 
MT binding assays: GMPCPP-stabilised, rhodamine-labeled MTs were grown from porcine 872 
brain tubulin and adhered to the surface of flow chambers (Helenius et al., 2006). 20 nM Efa6-873 
Cterm::GFP (in BRB20 pH 6.9, 75mM KCl, 0.05% Tween20, 0.1 mg/ml BSA, 1% 2-874 
mercaptoethanol, 40mM glucose, 40 mg/ml glucose oxidase, 16 mg/ml catalase) or 20 nM 875 
MCAK::GFP (in the same buffer plus 1 mM ATP and 1 mM taxol) was introduced to the MT-876 
containing channel. Images were recorded using a Zeiss Observer.Z1 microscope equipped 877 
with a Zeiss Laser TIRF 3 module, QuantEM 512SC EMCDD camera (Photometrics) and 878 
100x objective (Zeiss, alphaPlanApo/1.46NA oil). Images of rhodamine-labeled MTs using a 879 
lamp as the excitation source and GFP fluorescence using TIRF illumination via a 488 nm 880 
laser were collected as described (Patel et al., 2016). For both rhodamine and GFP imaging 881 
an exposure time of 100 ms was used. The mean GFP intensity on individual MTs was 882 
determined from the mean pixel intensity of lines drawn along the long-axis of individual 883 
microtubules in Fiji (Schindelin et al., 2012). The rhodamine signal was used to locate the 884 
position of MTs in the GFP images. Intensity from a region of background was subtracted. 885 
MT depolymerisation assays: GMPCPP-stabilised, rhodamine-labelled MTs were grown 886 
from porcine brain tubulin and adhered to the surface of flow chambers (Helenius et al., 2006). 887 
Images of a field of fluorescent microtubules were recorded using a Zeiss Observer.Z1 888 
microscope, collecting 1 image every 5 s with an exposure time of 100 ms. Efa6-Cterm::GFP 889 
(14 nM), MCAK (40 nM) in solution (BRB20 pH 6.9, 75mM KCl, 1mM ATP, 0.05% Tween 20, 890 
0.1 mg/ml BSA, 1% 2-mercaptoethanol, 40mM glucose, 40 mg/ml glucose oxidase, 16 mg/ml 891 
catalase) were added to the channel 1 min after acquisition had commenced. 892 
Depolymerisation rates were determined from plots of the length of individual microtubules 893 
versus time, obtained by thresholding and particle analysis of images using Fiji (Schindelin et 894 
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al., 2012).  895 
Microtubule growth assays: 30 M 25% rhodamine-labelled porcine brain tubulin was 896 
incubated in 80 mM PIPES pH6.9, 5 mM MgCl2, 1 mM EGTA, 5% DMSO and 1 mM GTP at 897 
37°C for 30 min in the presence of either no peptide, 30 M MTED peptide 898 
(APRFEAYMMTGDLILNLSRT; synthesised by Genosphere Biotechnologies Genscript), 30M 899 
scrambled peptide (MITAPREFDYLNLRAGLSMT; synthesised by Genosphere 900 
Biotechnologies) or 8 M MCAK (1mM Mg.ATP was included with MCAK). To stabilise MTs 901 
and to reduce their density so that they can be easily imaged, the reactions were then diluted 902 
200-fold into BRB80 buffer (80 mM PIPES pH6.9, 1 mM MgCl2, 1 mM EGTA) containing 1 mM 903 
taxol. Samples were added to poly-lysine coated cover glasses and imaged by fluorescence 904 
microscopy. The amount of tubulin polymer in each field of view was quantified by segmenting 905 
the images into background and microtubules by application of a threshold and measuring the 906 
total area of tubulin polymer for each image. 5 fields of view were quantified from each of two 907 
separate experiments 908 
Tubulin pull-down assays: MTED peptide or scrambled peptide was coupled (5 ng 909 
peptide/l beads) via the N-terminal amine to cyanogen bromide-activated Sepharose beads 910 
(GE Healthcare). 15 M porcine brain tubulin was incubated with either MTED peptide-coated, 911 
scrambled peptide-coated or uncoated sepharose beads in BRB80 with 0.2% Tween 20 for 30 912 
mins at 20°C. The beads were washed five times with a 2:1 v/v ratio of BRB80 with 0.2% 913 
Tween 20 to beads. An equal volume of 2x Laemmli buffer was added to the washed beads, 914 
incubated at 90°C for 5min, spun down and the supernatant run on a 12% SDS-PAGE gel. 915 
The intensity of the bands was quantified in FIJI. Full length human MCAK was coupled (1µg/ 916 
µl beads) to cyanogen bromide-activated Sepharose beads via any solvent exposed lysine or 917 
the N-terminal amine. MCAK coated beads were incubated with 5 mM AMPPNP or ADP for 918 
30 min at 20°C and then incubated with 15 M porcine brain tubulin for 30 mins at 20°C. The 919 
beads were then treated as for peptide-coated beads (above) but with inclusion of the 920 
appropriate nucleotide in the washing buffer. 921 
Xenopus assays: cytosol extracts from Xenopus oocytes were obtained as described 922 
previously (Allan and Vale, 1991). MT depolymerisation was assessed in a microscopic flow 923 
chamber (Vale and Toyoshima, 1988) where Xenopus cytosol (1 µl cytosol diluted with 20 µl 924 
acetate buffer) was incubated for 20 min to allow MTs to polymerise. Then cytosol was 925 
exchanged by flow through with Efa6-ΔCterm::GFP, MCAK or synthetic MTED peptide (all 20 926 
nM  in acetate buffer pH 7.4: 100 mM K-Acetate, 3 mM Mg-Acetate, 5 mM EGTA, 10 mM 927 
HEPES), and MT length changes observed by recording 10 random fields via VE-DIC 928 
microscopy (Allan, 1993; Allan and Vale, 1991). MT polymerisation was analysed in a 929 
microscope flow cell containing 9 µl diluted Xenopus cytosol (see above) to which 1 µl acetate 930 
buffer was added, either alone or containing 20 nM MTED. After 10 min, 20 random fields 931 
were recorded via VE-DIC microscopy for each condition and the numbers of MTs per field 932 
counted. 933 
For the in vivo assay, Xenopus embryos were injected in one blastomere at the 4-cell stage 934 
with 200 ng of mRNA encoding Efa6-Nterm::GFP or mCherry alone. The embryos were 935 
imaged at stage 10.25 (Heasman, 2006) with a Leica fluorescent stereoscope. 936 
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Figures 1227 
 1228 
Figure 1. Efa6 is expressed throughout neurons at all developmental stages 1229 
A-B) Late larval CNSs at about 4d after egg lay (L3; A,B) and adult CNSs from 10d old flies 1230 
(C,D) derived from control wild-type animals (wt) or the Efa6::GFP line (Efa6::GFP), stained 1231 
for GFP and actin (Phalloidin, only larval preparations); OL, optic lobe; Br, central brain; vNC, 1232 
ventral nerve cord. E-I) Images of primary Drosophila neurons at 6HIV or 5DIV (as indicated 1233 
bottom right), stained for tubulin (magenta) and GFP (green); control neurons are wild-type 1234 
(wt) or express elav-Gal4-driven nuclear GFP (elav / nl-GFP), further neurons are either 1235 
derived from the endogenously tagged Efa6::GFP line or express Efa6-FL::GFP under the 1236 
control of sca-Gal4 (sca / Efa6-FL::GFP); asterisks indicate cell bodies and arrows the axon 1237 
tips. Scale bar in A represent 75µm in A and B, 130µm in C and D, 15µm in E-H, 25µm in I 1238 
and E. 1239 
 1240 
Figure 2. Efa6 regulates axonal length in primary Drosophila neurons. Examples of primary 1241 
Drosophila neurons at 6HIV (A-C), all stained for actin (magenta) and tubulin (green); neurons 1242 
are either wild-type controls (A), Efa6-deficient (B), or expressing Efa6-FL::GFP (C); asterisks 1243 
indicate cell bodies, arrows point at axon tips; the scale bar in C represents 10µm. 1244 
Quantification of axon lengths at 6HIV (D); different genotypes are colour-coded: grey, wild-1245 
type controls; blue, different Efa6 loss-of-function conditions; green, neurons over-expressing 1246 
Efa6; data represent fold-change relative to wild-type controls (indicated as horizontal dashed 1247 
"ctrl" line); they are shown as single data points and a bar indicating mean ± SEM data; P 1248 
values from Mann-Whitney tests are given above each column, sample numbers at the bottom 1249 
of each bar represent individual neurons pooled from at least two replicates, i.e. experiments 1250 
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conducted on different days. For raw data see Figure 2-source data 1. 1251 
 1252 
Figure 3. Efa6 domain and motif requirements for MT inhibition in neurons and fibroblasts. A) 1253 
Schematics of Drosophila melanogaster (Dm) Efa6 (isoform C; CG31158), Caenorhabditis 1254 
elegans (Ce) Efa6 (isoform Y55D9A.1a) and Homo sapiens (human) PSD1 (isoform 201/202; 1255 
NP_002770.3), illustrating the positions (numbers indicate first and last residues) of the 1256 
putative PDZ (PSD95-Dlg1-ZO1) domain [expected to anchor to transmembrane proteins 1257 
(Ponting et al., 1997), but not mediating obvious membrane association in fibroblasts: Figure 1258 
3-figure supplement 6C,D], SxIP/SxLP motifs (SRIP, SQIP, SALP, SSLP), the MT-eliminating 1259 
domain (MTED), SEC7 domain, plekstrin homology (PH) domain and coiled-coil domain (CC). 1260 
B) Schematics on the left follow the same colour code and show the DmEfa6 constructs used 1261 
in this study (dashed red lines indicate the last/first residue before/behind the truncation). Bar 1262 
graphs on the right show the impact that transfection of these constructs had on axon loss in 1263 
primary Drosophila neurons (dark grey in left graph) and on MT loss in fibroblasts (dark grey 1264 
or black as indicated; for respective images see F and G below). Analogous fibroblast 1265 
experiments as performed with Drosophila constructs were performed with full length 1266 
constructs of C. elegans Efa6 and human PSDs (C), with N-terminal constructs (D) or 1267 
synthetic MTEDs (E) of Dm and CeEfa6 and of human PSD1. Throughout this figure, 1268 
construct names are highlighted in red for Drosophila, light blue for C. elegans and yellow for 1269 
Homo sapiens; all graph bars indicate percentages of neurons with/without axons (light/dark 1270 
grey) and of fibroblasts with normal, reduced or absent MTs (light, medium, dark grey, 1271 
respectively); numbers in the left end of each bar indicate sample numbers indicating 1272 
individual cells pooled from at least two replicates, on the right end the P values from Chi2 1273 
tests relative to GFP controls; numbers on the right of bars in B compare some constructs to 1274 
Efa6-FL::GFP, as indicated by black lines. F-F’’) Primary neurons expressing GFP or Efa6-1275 
FL::GFP transgenically and stained for tubulin (asterisks, cell bodies; white arrows, axon tips; 1276 
open arrow, disintegrated or absent axon). G-G'') Fibroblasts expressing Efa6-FL::GFP and 1277 
stained for tubulin; curved arrows indicate areas where MTs are retracted from the cell 1278 
periphery; grey dots in F-G'' indicate the phenotypic categories for each neuron and 1279 
fibroblasts, as used for quantitative analyses in the graphs above. Scale bar at bottom of F 1280 
refers to 10µm in F and 25µm in G. For raw data see Figure 3-source data 1. 1281 
 1282 
Figure 3-figure supplement 1. Localisation of Efa6 constructs in primary neurons. Images 1283 
show transfected primary Drosophila neurons at 18HIV stained for tubulin (magenta) and GFP 1284 
(green and in greyscale below the colour image). Cell bodies are indicated by asterisks, axon 1285 
tips by arrows. The transfected constructs are indicated top right following the nomenclature 1286 
explained in Figure3B. Scale bar in A represents 10µm for all figures shown.  1287 
 1288 
Figure 3-figure supplement 2. MT inhibition by Efa6-FL is concentration-dependent in 1289 
fibroblasts. A-C) Representative images of fibroblasts stained for GFP and tubulin (green and 1290 
magenta, respectively; both shown as single channels in greyscale below the colour image). 1291 
Images were taken 24hrs after transfection with Efa6-FL::GFP, assessed for GFP intensity 1292 
(plotted on the ordinate in D). Examples for low, moderate and high expression are given in A, 1293 
B and C, respectively, and then grouped with respect to their MT phenotypes into 'MTs intact' 1294 
(light grey), 'moderate MT defects' (medium grey) or 'prominent MT networks gone' (black), as 1295 
indicated by greyscale circles in the lowest row of A-C and the abscissa of D; red numbers 1296 
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above box plots indicate number of cells contained in each data set. Arrow heads point at 1297 
GFP accumulation at membrane edges, white curved arrows indicate cell compartments from 1298 
which MTs have retracted, open arrows point at retraction fibres and the double chevron 1299 
indicates the nucleus position and signs of nuclear GFP localisation. Scale bar in A represents 1300 
10µm in all images. For raw data see Figure 3-source data 2. 1301 
  1302 
Figure 3-figure supplement 3. Representative MT phenotypes induced by the different 1303 
constructs in transfected fibroblasts. Fibroblasts 24hrs after transfection with different control 1304 
(GFP) or Efa6-derived constructs as indicated top right in each image (nomenclature as 1305 
explained in Figure 3B, but leaving out the “Efa6“-prefix and “::GFP”-postfix). Cells were 1306 
stained for tubulin (black; images shown as inverted greyscale) and classified as 'no MT 1307 
defects' (light grey), 'moderate MT defects' (medium grey) or 'prominent MT networks gone' 1308 
(black), as indicated by greyscale boxes bottom left of each image; curved arrows indicate 1309 
peripheral MT depletion. Each image represents the most prominent phenotype for each 1310 
respective construct. Scale bar at the bottom right in H represents 25µm in all images.  1311 
 1312 
Figure 3-figure supplement 4. Efa6 N-terminal domains vary amongst different phyla. A) 1313 
Domain annotations in 56 Efa6 orthologues via EMBL SMART and Uniprot. Phyla are colour-1314 
coded as in Figure 3 and Figure 3-figure supplement 5. Note that there is a strong variation of 1315 
lengths and domain composition in particular of the N-terminus. The putative PDZ domain 1316 
seems to be a feature mainly of insect versions of Efa6 and is absent from any analysed 1317 
chordate orthologues; MTED and MTED-like sequences cannot be consistently identified in all 1318 
Efa6 orthologues and are very divergent in chordate Efa6/PSD versions. SxIP/SxLP sites 1319 
(flanked by positive charges as would be expected of functional motifs; Honnappa et al., 2009) 1320 
are found in the N-terminal half of only a subset of Efa6 versions in nematodes (e.g. C. 1321 
elegans), insects (in particular flies, e.g. D. melanogaster) and molluscs, and even fewer in 1322 
chordates; in mouse, alpaca and cat SxIP/SxLP sites are flanked by negative charges. B) To 1323 
determine a potential MTED consensus sequence, 37 sequences of molluscs, nematodes, 1324 
arthropods and putative MTED sequences of mammalian PSD1-4 were grouped according to 1325 
phylum; consensus sequences were depicted using Berkley’s Weblogo online server (default 1326 
colour scheme). Amino acid positions identical to D. melanogaster and C. elegans MTED are 1327 
highlighted (faint yellow).  1328 
 1329 
Figure 3-figure supplement 5. Phylogentic tree analysis of Efa6. Bayesian phylogenetic 1330 
analysis of Efa6 orthologues, either full length (A) or their N-terminus (B). Sequences were 1331 
aligned using Muscle or ClustalO and posterior probabilities and branch lengths calculated 1332 
using MrBayes. Branch length scale is indicated; blue numbers show posterior probabilities of 1333 
each branch split. As outgroup for the full length tree, we used Drosophila steppke (step; 1334 
Hahn et al., 2013). In both full length and N-terminus analyses, chordates (cream colour) split 1335 
off very early from Efa6 versions of other species, in line with an early speciation event 1336 
separating both groups before the vertebrate multiplication events took place. Phyla are 1337 
highlighted in different colours, gene symbols and/or accession numbers are given after the 1338 
species names.  1339 
 1340 
Figure 3-figure supplement 6. Efa6 constructs localisations in fibroblasts. Images show 1341 
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fibroblasts 24hrs after transfection with control (GFP) or Efa6-derived constructs 1342 
(nomenclature as explained in Figure 3B, but leaving out the “Efa6“-prefix and “::GFP”-postfix, 1343 
as indicated top right); all cells are stained for GFP (green) and either for actin or MTs 1344 
(magenta) as indicated bottom right; GFP and actin/MTs are shown as single channels in 1345 
greyscale below the colour images,  Double chevrons indicate nuclear localisation, arrow 1346 
heads membrane localisation apparent at cell edges and curved arrows membrane ruffles. 1347 
Scale bar in A represents 10µm in all images.  1348 
 1349 
Figure 3-figure supplement 7. Conserved functions of the Efa6 C-terminus in membrane 1350 
ruffle formation. A-E) Representative images of fibroblasts 24hrs after transfection with 1351 
different constructs (indicated top right): control vector (GFP; A), Efa6-derived constructs (B-1352 
D; nomenclature as explained in Figure 3B, but leaving out the “Efa6“-prefix and “::GFP”-1353 
postfix) or PSD1-FL::GFP (E). All cells were stained for GFP and actin (green and magenta, 1354 
respectively; both shown as single channels in greyscale below the colour images). To the 1355 
right of each image, a selected area is displayed with 2.5-fold magnification, showing dotted 1356 
actin- and GFP-stained ruffles (curved open arrows) in B, D and E, but not A and C. F) Ruffle 1357 
formation was quantified and is shown as a bar graph indicating percentages of fibroblasts 1358 
with/without membrane ruffles (dark/light grey); P values on top of bars are from Chi2 tests 1359 
relative to GFP controls. As shown, ruffle phenotype were never observed with any N-terminal 1360 
Efa6 variants but are reproduced with the Efa6-∆Nterm::GFP variant (comprising the C-1361 
terminal Sec7, PH and CC domains; Figure 3B). Scale bar in A represents 10 µM for all 1362 
fibroblasts shown. For sample numbers and raw data see Figure 3-source data 3. 1363 
 1364 
Figure 4. EFA6 peptide interacts directly with /-tubulin and inhibits microtubule growth. A-1365 
C) Fibroblasts co-expressing Eb3::RFP (magenta) together with either GFP (A), Efa6-FL::GFP 1366 
(B) or Efa6-Nterm::GFP::CAAX (C; all shown in green); images are maximum intensity 1367 
projections of all frames taken at 1 s intervals during a 120 s live imaging period; stippled 1368 
areas are shown as 2.5fold magnified insets. Example movies are provided as Video 1, 2 and 1369 
4. D,E) Quantification of Eb3::RFP comet behaviours deduced from images comparable to 1370 
those shown in A to C: in D, each data point represents the number of comets that were within 1371 
a 1 µm range from the perimeter assessed over a 50μm perimeter stretch, respectively (n=73 1372 
for GFP, 90 for Efa6-FL::GFP and 90 for Efa6-Nterm::GFP::CAAX); in E, each data point 1373 
represents the distance individual Eb3 comets reached into GFP-positive areas (in B and C 1374 
assessed in areas of high GFP expression, in A in areas close to the perimeter; n=224 for 1375 
GFP, 238 for Efa6-FL::GFP and 197 for Efa6-Nterm::GFP::CAAX). F) Pull-down of porcine 1376 
brain tubulin using sepharose beads which were either uncoated, or coated with MTED, with a 1377 
scrambled version of MTED or with MCAK (in the presence of ADP or the ATP analogue 1378 
AMPPNP); proteins/peptides were randomly attached via cyanogen bromide coupling of 1379 
lysines and/or N-terminal amines; quantification data are provided as Figure 4-source data 1. 1380 
G) Fluorescence images of rhodamine-labelled MTs grown in the presence of no peptide, 1381 
MTED, scrambled MTED or MCAK together with ATP. H) Quantification of the amount of MT 1382 
polymer per field of view (n=10 fields in each case; AU, arbitrary unit). Numbers above plots in 1383 
D, E and F represent P-valued determined via  Kruskal–Wallis one-way ANOVA with post hoc 1384 
Dunn’s test. Scale bar in A represents 10 µm in A-C and 3 in G. For raw data see Figure 4-1385 
source data 1. 1386 
 1387 
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Figure 4-figure supplement 1. In vitro attempts to resolve the MT inhibition mechanism of 1388 
Efa6. A) To determine whether Efa6 directly affects MT stability, we expressed Efa6-1389 
∆Cterm::GFP in Sf9 cells, purified the protein and observed its interaction with MTs using total 1390 
internal reflection fluorescence (TIRF) microscopy in a low ionic strength buffer (BRB20, 1391 
75mM KCl); the three images on the left show different examples of kymographs of MT 1392 
lattices decorated with Efa6-∆Cterm::GFP, which displays a mixture of stationary molecules 1393 
and diffusive interactions typical of non-translocating MT-associated proteins (Helenius et al., 1394 
2006; Hinrichs et al., 2012); bar charts (right) show quantification of the amount of interacting 1395 
protein: background signal from MTs alone, Efa6-Cterm::GFP (20nM), and the non-1396 
translocating kinesin MCAK::GFP (20nM) as positive control; at the same protein 1397 
concentration, over 2-fold more molecules of MKAC typically interact with MTs; individual data 1398 
points represent mean intensity of individual MTs (sample numbers at bottom) and bars 1399 
represent mean ± SEM; numbers above bars show P values obtained from Mann–Whitney 1400 
Rank Sum statistical analyses. B) Kymographs (left) show individual fluorescently-labelled 1401 
GMPCPP-stabilised MTs in vitro (Patel et al., 2016), either alone (MTs only) or in the 1402 
presence of 14 nM Efa6-Cterm::GFP (n=20) or 40nM MCAK::GFP; the bar chart (right) 1403 
quantifies the induced depolymerisation rates (number of analysed MTs at bottom). Using two 1404 
different purifications of Efa6-Cterm::GFP on three separate occasions, we saw no evidence 1405 
of MT depolymerisation above the basal level of depolymerisation typically observed in these 1406 
assays, whereas parallel control experiments with mitotic centromere-associated 1407 
kinesin/MCAK showed MT depolymerisation rates typical of this kinesin. C) To assess 1408 
whether MT destabilisation might require additional cytoplasmic factors, we used Xenopus 1409 
oocyte extracts: phase contrast images show MTs in Xenopus oocyte extracts (after they had 1410 
been allowed to polymerise for 20 min) and then showing stills from before, 10s after and 1411 
120s after washing in 20 nM MCAK::GFP (as positive control) or 20 nM Efa6-Cterm::GFP; 1412 
squares outlined by dashed white lines are shown as 2-fold magnified close-ups in the top 1413 
right corner of each image; MTs clearly vanish upon treatment with MCAK, but counts of MTs 1414 
did not reveal any obvious effects on MTs with Efa6-Cterm::GFP. D,E) RFP controls and 1415 
Efa6-Nterm::GFP expression constructs were injected into Xenopus embryos at the 4-cell 1416 
stage and analysed 24 hrs later; only the Efa6 construct caused a strong suppression of cell 1417 
division, as indicated by the presence of very large cells (arrows) and pigmentation defects 1418 
(curved arrows) at the site of injection, suggesting that Efa6-Nterm::GFP is functional when 1419 
expressed in the Xenopus context. Scale bar (in top left image) represents 3 µm in C, and 1420 
1400 µm / 350 µm / 140 µm in left / middle / right images of D and E, respectively. For raw 1421 
data see Figure 4-source data 2. 1422 
 1423 
Figure 5. Efa6 regulates MT behaviours in GCs. A-H') Examples of primary neurons at 6HIV 1424 
which are either wild-type controls (top), Efa6-deficient (middle) or expressing Efa6-FL::GFP 1425 
(bottom); neurons were either imaged live for Eb1::GFP (green in A,D) or fixed and labelled 1426 
for Eb1 and tubulin (B,E,G; as colour-coded) or actin and tubulin (C,F,H; as colour coded; 1427 
tubulin shown as single channel image on the right); asterisks indicate cell bodies, white 1428 
arrows the tips of GCs, open arrows the tips of MT bundles, arrow heads filopodial processes 1429 
containing MTs or Eb1 comets; the GC in G is outlined with a white dashed line; scale bar in D 1430 
represents 5µm in all images. I-M) Quantitative analyses of MT behaviours in GCs, as 1431 
indicated above each graph. Different genotypes are colour-coded: grey, wild-type controls; 1432 
blue, different Efa6 loss-of-function conditions; green, neurons over-expressing Efa-FL. The 1433 
graph in L shows percentages of neurons without any MTs in shaft filopodia (dark shade) 1434 
versus neurons with MTs in at least one filopodium (light shade; P values above bars 1435 
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assessed via Chi2 tests), whereas all other graphs show single data points and a bar 1436 
indicating mean ± SEM, all representing fold-increase relative to wild-type controls (indicated 1437 
as horizontal dashed "ctrl" line; P values above columns are from Mann-Whitney tests. The 1438 
control values in M (dashed line) equate to an Eb1 comet life-time of 2.10s ± 0.24SEM in 1439 
filpododia and 5.04s ± 0.60SEM in growth cones, and a comet velocity of 0.136 μm/s ± 1440 
0.01SEM. Throughout the figure, sample numbers are shown at the bottom of each bar where 1441 
each data point represents one GC (I-K), one neuron (L) or one Eb1::GFP comet (M), 1442 
respectively; in all cases data were pooled from at least two replicates; data obtained from live 1443 
analyses with Eb1::GFP are framed in red. For raw data see Figure 5-source data 1. 1444 
 1445 
Figure 6. Loss of Efa6 promotes MT entry into axon shaft filopodia. Quantitative analyses of 1446 
MT behaviours in axon shafts, as indicated above each graph; bars are colour-coded: grey, 1447 
controls; blue, different Efa6 mutant alleles; green, neurons over-expressing Efa-FL::GFP or 1448 
Efa6::CAAX::GFP; orange, shot3 mutant allele; red outlines indicate live imaging data, all 1449 
others were obtained from fixed specimens. A-C,G) Fold-changes relative to wild-type controls 1450 
(indicated as horizontal dashed "ctrl" line) shown as single data points and a bar indicating 1451 
mean ± SEM; P values were obtained via Mann-Whitney tests; control values (dashed line) in 1452 
B and C equate to an Eb1 comet lifetime of 7.18 s ± 0.35 SEM and a velocity of 0.169 μm/s ± 1453 
0.01SEM. D-F) Binary parameters (light versus dark shades as indicated) provided as 1454 
percentages; in G the number of shaft filopodia per neuron was divided by the axon length of 1455 
that same neuron. P values are given relative to control or between different genotypes (as 1456 
indicated by black lines); they were obtained via Chi2 tests. Numbers at the bottom of bars 1457 
indicate sample numbers pooled from at least two replicates, respectively; data points reflect 1458 
individual Eb1::GFP comets (A-D) or individual neurons (E-G). For raw data see Figure 6-1459 
source data 1. 1460 
 1461 
Figure 7. Efa6 regulates axon branching in primary Drosophila neurons and adult fly brains. 1462 
A-D) Examples of primary Drosophila neurons at 5DIV, all stained for actin (magenta) and 1463 
tubulin (green); neurons are either wild-type controls (A), Efa6-deficient (B), expressing Efa6-1464 
FL::GFP (C), or expressing Efa6-Nterm-CAAX::GFP (D); asterisks indicate cell bodies, arrows 1465 
point at axon tips, arrow heads at axon branches, the curved arrow at an area of MT 1466 
disorganisation; the scale bar in C represents 20µm in A-D. E) Quantification of axonal branch 1467 
numbers; different genotypes are colour-coded: grey, wild-type controls; blue, Efa6 loss-of-1468 
function; green, neurons over-expressing Efa6 variants; data represent fold-change relative to 1469 
wild-type controls (indicated as horizontal dashed "ctrl" line); each neuron is shown as a single 1470 
data point (sample number at bottom of bar) together with the mean ± SEM; P values from 1471 
Mann-Whitney tests comparing to wild-type are given above each column. F-K) Brains 1472 
(medulla region of the optic lobe in oblique view) of young (2-5 d after eclosure; top) and old 1473 
flies (15-18 d; bottom) driving UAS-myr-tdTomato via the ato-Gal4 driver in dorsal cluster 1474 
neurons (example neurons are traced in magenta for axons and green for side branches); flies 1475 
either carry ato-Gal4-and UAS-myr-tdTomato, alone (control, left), together with Efa6-RNAi 1476 
(middle) or together with Efa6-FL::GFP (right). L,M) Quantification of data for control (wt; grey), 1477 
Efa6 knock-down (blue) and Efa6-FL::GFP over-expression (green): L) shows the number of 1478 
primary branches per axon as fold-change normalised to controls (indicated as horizontal 1479 
dashed "ctrl" line); individual axons are shown as data points (sample number at bottom of 1480 
bars indicate number of medullas before and number of axons after slash); bars indicate 1481 
mean ± SEM accompanied by single data points. M) displays the number of medullas (sample 1482 
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numbers at bottom of bars) which display axons (light colours) or lack axons (dark colours) 1483 
shown as a percentages in young and old flies. P values above columns were obtained from 1484 
Mann-Whitney (L) or Chi2 tests (M). Scale bar in I represents 60µm in F-K. For raw data see 1485 
Figure 7-source data 1. 1486 
 1487 
Figure 7-figure supplement 1. ato-Gal4-driven Efa-FL::GFP expression in adult brain tissue. 1488 
Images show the optic lobe in oblique view; white dashed line indicating the lower edge of the 1489 
medulla) of young (2-5 d after eclosure; top) and old flies (15-18 d; bottom) which are either 1490 
from wild-type controls or from flies co-expressing UAS-myr-tdTomato  and UAS-Efa6-FL-GFP 1491 
via the ato-Gal4 driver in dorsal cluster neurons. Specimens are stained for GFP and arrows 1492 
point at stained axons; for morphological stainings of ato-Gal4 axons in these experiments 1493 
see Figure 7F-K. Scale bar in A represents 60µm in all images. 1494 
 1495 
Figure 8. Efa6 helps to maintain axonal MT bundles in Drosophila neurons. A-H) Images of 1496 
primary neurons at 6HIV (left), 5DIV (middle) and 10DIV (right), stained for tubulin (green) and 1497 
actin (magenta), derived from embryos that were either wild-type (wt, A-C), Efa6 null mutant 1498 
(D-F), homozygous for shot3 (G) or shot3 Efa6GX6[w-]  double-mutant (shot Efa6, H); arrows 1499 
point at axon tips, arrow heads at areas of MT disorganisation, and asterisks indicate the cell 1500 
bodies; the scale bar in A represents 10µm for 6HIV neurons and 25µm for 5DIV and 10DIV 1501 
neurons. I-N) Quantitative analyses of MT disorganisation (measured as MT disorganisation 1502 
index, MDI) in different experimental contexts (as indicated above graphs); different 1503 
genotypes are colour-coded: grey, controls; blue, Efa6 loss-of-function; orange, shot3 in 1504 
hetero-/homozygosis; green, neurons over-expressing Efa-FL::GFP or Efa6-1505 
NtermCAAX::GFP; in all cases, individual neurons are shown as single data points (sample 1506 
numbers at bottom of bar), and the bars indicate mean ± SEM, all representing fold-change 1507 
relative to wild-type controls (indicated as horizontal dashed "ctrl" line); P values are given 1508 
above each column and were obtained from Mann-Whitney tests (I, J) and Kruskal–Wallis 1509 
one-way ANOVA with post hoc Dunn’s test (K-N) either relative to controls or between 1510 
genotypes (indicated by black lines). In K, 'control 1' is tub-Gal80, elav-Gal4 alone and 'control 1511 
2' is UAS-Efa6RNAi alone. For raw data see Figure 8-source data 1. 1512 
 1513 
Figure 9 Efa6 is required for axonal MT bundle maintenance in adult fly brains. A-C) Medulla 1514 
region of adult brains at 26-27 days after eclosure, all carrying the GMR31F10-Gal4 driver and 1515 
UAS-GFP--tubulin84B (GMR-tub) which together stain MTs in a subset of lamina neuron 1516 
axons that terminate in the medulla. The other specimens in addition co-express Efa6-RNAi 1517 
either in wild-type background (GMR-tub-Efa6IR) or in shot3/+ heterozygous mutant 1518 
background (GMR-tub-Efa6IR shot3/+). White/black arrows indicate axonal swellings 1519 
without/with MT disorganisation; rectangles outlined by red dashed lines are shown as 2.5 fold 1520 
magnified insets where white arrow heads point at disorganised MTs; the scale bar in A 1521 
represents 15µm in all images. D, E) Quantitative analyses of all axonal swelling (D) or 1522 
swellings with MT disorganisation (E); different genotypes are colour-coded (grey, control; 1523 
blue, Efa6 loss-of-function; orange, shot3 heterozygous); bars show mean ± SEM, all 1524 
representing fold-change relative to wild-type controls (indicated as horizontal dashed line). P 1525 
values from Kruskal–Wallis one-way tests are given above each column, sample numbers (i.e. 1526 
individual axon bundles) at the bottom of each bar. For raw data see table Figure 9-source 1527 
data 1. 1528 
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 1529 
Figure 10. A model for axonal roles of Efa6. A) The model of local axon homeostasis (Hahn 1530 
et al., 2019; Prokop, 2016) states that the maintenance of axonal MT bundles (green bars) is 1531 
an active process. For example, the polymerisation (1) mediated by plus end machinery (blue 1532 
circle) is guided by spectraplakins (here Shot) along cortical actin into parallel bundles (2), or 1533 
MTs are kept together through cross-linkage (brown “L”; 4; Bettencourt da Cruz et al., 2005; 1534 
Krieg et al., 2017); here we propose that MTs accidentally leaving the bundle become 1535 
susceptible to inhibition through cortically anchored Efa6 (red “T” and orange circle). B) In 1536 
normal neurons, MTs that polymerise within the axonal bundles (dark blue circles) are 1537 
protected by Shot (grey lines) and MT-MT cross-linkers (brown rectangles), whereas MTs 1538 
approaching the membrane (orange arrow heads) either by splaying out in GCs or leaving the 1539 
bundle in the shaft (orange arrow heads) become susceptible (orange circles) to inhibition by 1540 
Efa6 (light green/red dashes) both along the cortex and in filopodia C) Upon Efa6 deficiency, 1541 
MTs leaving bundles or entering GCs are no longer subjected to Efa6-mediated cortical 1542 
inhibition (blue arrow heads) and can cause gradual build-up of MT disorganisation; when 1543 
entering shaft filopodia they can promote interstitial branch formation (red arrow), when 1544 
entering GC filopodia they can promote axon growth or even branching through GC splitting 1545 
(yellow arrows). D) Far more MTs leave the bundles in shot mutant neurons, but a good 1546 
fraction of them is inhibited by Efa6 (increased number of orange arrow heads). E) In the 1547 
absence of both Shot and Efa6, more MTs leave the bundles, but there is no compensating 1548 
cortical inhibition (increased number of blue arrow heads), so that the MT disorganisation 1549 
phenotype worsens.  1550 
 1551 
Video 1. MT behaviours in control fibroblasts expressing GFP. Transfected fibroblasts co-1552 
expressing Eb3::RFP (green) to visualise MT polymerisation, together with GFP (magenta) 1553 
which localises throughout the cell. White boxed areas are shown as twofold magnified close-1554 
ups on the right. MTs clearly polymerise to the very perimeter of the transfected cell 1555 
(quantifications are shown in Figure 4). Movies were taken at one frame per second. The 1556 
scale bar corresponds to 25 μm in the main image. 1557 
Video 2. MT behaviours in control fibroblasts expressing Efa6-FL::GFP. Transfected 1558 
fibroblasts co-expressing Eb3::RFP (green) to visualise MT polymerisation, together with 1559 
Efa6-FL::GFP (magenta) which localises primarily to the cell periphery. White boxed area is 1560 
shown as twofold magnified close-up on the right, separated by channel. MTs clearly fail to 1561 
polymerise into the  Efa6-FL::GFP-enriched zone and hardly ever reach the cell perimeter 1562 
(quantifications are shown in Figure 4). Movies were taken at one frame per second. The 1563 
scale bar corresponds to 25 μm in the main image. 1564 
Video 3. Eb1::GFP tip-tracks in fibroblasts. Upon Eb1::GFP expression in mouse NHTH3 1565 
fibroblast about 6 hours after transfection, comets were observed in a few instances. Pictures 1566 
for the movie were taken at 2 s intervals. Scale bar indicates 10 µm. 1567 
Video 4. MT behaviours in control fibroblasts expressing Efa6-Nterm::GFP::CAAX. 1568 
Transfected fibroblasts co-expressing Eb3::RFP (green) to visualise MT polymerisation, 1569 
together with Efa6-Nterm::GFP::CAAX (magenta) which localises primarily to the cell 1570 
periphery. The close-up on the right is two-fold magnified and refers to the top left corner of 1571 
the main image; it is separated by channel. MTs fail to polymerise into the Efa6-1572 
Nterm::GFP::CAAX-enriched zone and hardly ever reach the cell perimeter (quantifications 1573 
are shown in Figure 4D,E). Movies were taken at one frame per second. The scale bar 1574 
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corresponds to 25 μm in the main image. 1575 
Video 5. Eb1::GFP in a growth cone of a wild-type Drosophila primary neuron at 6 HIV. 1576 
Arrows indicate positions where individual Eb1::GFP comets terminate. Pictures of the movie 1577 
were taken at 2 s intervals. Scale bar indicates 10 µm. 1578 
Video 6. Eb1::GFP in a growth cone of a wild-type Drosophila primary neuron at 6 HIV. 1579 
Arrows indicate positions where individual Eb1::GFP comets terminate. Pictures of the movie 1580 
were taken at 2 s intervals. Scale bar indicates 10 µm. 1581 
Video 7. Eb1::GFP in a growth cone of an Efa6 GX6[w-] mutant Drosophila primary neuron at 6 1582 
HIV. The arrow heads follow individual Eb1::GFP comets illustrating either their trajectories 1583 
adjacent to the membrane or prolonged dwell time at filopodial tips. Pictures for the movie 1584 
were taken at 2 s intervals. Scale bar indicates 10 µm.  1585 
Video 8. Eb1::GFP in a growth cone of an Efa6 GX6[w-] mutant Drosophila primary neuron at 6 1586 
HIV. The arrow heads follow individual Eb1::GFP comets illustrating either their trajectories 1587 
adjacent to the membrane or prolonged dwell time at filopodial tips. Pictures for the movie 1588 
were taken at 2 s intervals. Scale bar indicates 10 µm. 1589 



















